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Abbreviations 
 
ADH  Alcohol dehydrogenase 
APS  Ammoniumperoxidisulphate 
ATP  Adenosine triphosphate 
bc1-complex Ubiquinol-cytochrome c oxidoreductase 
C-terminus Carboxyl-terminus 
DMSO Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
dNTP  Deoxynucleosidtriphosphate 
DSP  Dithiobis(succinimidylpropionate) 
DTT  Dithiothreitol 
EDTA  Ethylendiamine-tetraacetic acid 
FADH2 Flavin adenine dinucleotide (reduced form of FAD) 
IM  Inner membrane 
IMS  Intermembrane space 
ISP  Rieske Fe-S protein 
mt  mitochondrial 
N- terminus Amino-terminus 
OD  Optical density 
OM  Outer membrane 
ORF  Open reading frame 
PAGE  Polyacrylamide gel electrophoresis 
PCR  Polymerase chain reaction 
PMSF  Phenylmethylsulfonyl fluoride 
PVDF  Polyvinylidene difluoride 
RT  Room temperature 
SDS  Sodium dodecyl sulphate 
SDS-PAGE Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
TEMED N`,N`,N`,N`- Tetramethylethylenediamine 
TM  Transmembrane 
TOM  The Translocase of the Outer Membrane of Mitochondria 
Tris  Tris(hydroxymethyl)aminomethane 
v/v  Volume per volume 
w/v  Weight per volume 
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Amino acids 
 
A Ala alanine   M Met methionine 
C Cys cysteine   N Asn asparagine 
D Asp aspartate   P Pro proline 
E Glu glutamate   Q Gln glutamine 
F Phe phenylalanine   R Arg arginine 
G Gly glycin    S Ser serine 
H His histidine   T Thr threonine 
I Ile isoleucine   V Val valine 
K Lys lysine    W Trp tryptophan 
L Leu leucine   Y Tyr tyrosine
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Aim of the work 
 
Ubiquinol-cytochrome c reductase (complex III) is a respiratory chain enzyme of the inner 
mitochondrial membrane, transferring electrons from reduced ubiquinone to ferricytochrome 
c. In Saccharomyces cerevisiae, ubiquinol-cytochrome c reductase is composed of 10 non-
identical subunits with defined catalytic centers consisting of cytochrome b, cytochrome c1 
and the Rieske FeS protein. Correctly assembled and functional complex III is an essential 
prerequisite for oxidative energy metabolism. Complex III deficiency has been reported to be 
associated with several neurodegenerative diseases. However, the assembly process is not 
fully understood and requires the involvement of different chaperones. Three non-subunit 
proteins, which are important for assembly and/or stability of complex III have been detected. 
The role of Bcs1p in assembly of Rieske FeS and Qcr10p into complex III was already 
shown. The role of two chaperones, Cbp3p and Cbp4p, is not known. 
This work will be focused on the characterization of both Cbp3p and Cbp4p proteins and their 
homologs in human and in Schizosaccharomyces pombe. It is planned to develop a yeast 
model to characterize hCBP3 mutations if some would be identified. The topology of both 
proteins, their ability to form homomers and/or heteromers, as well as their potential to 
substitute for each other will be analysed. Experiments to exclude the possible roles of the 
two assembly factors in lipid metabolism (e. g. cardiolipin synthesis) will be performed. To 
define the roles of the two proteins in complex III assembly, the interactions of the two 
proteins with selected subunits of complex III will be investigated using TAP-method or co-
immunoprecipitation. Moreover, to identify the pathway of complex III assembly and the 
steps, in which Cbp3p and/or Cbp4p act, the assembly of complex III subunits in wild type, 
cbp3 and cbp4 null mutants will be monitored using the technique of Blue Native PAGE (BN-
PAGE). 
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1. INTRODUCTION 
 
Mitochondria are essential organelles present in nearly all eukaryotic cells. They are separated 
from the cytosol by two membranes that are very different in protein and lipid composition. 
The outer membrane is composed of about half lipid and half protein. Transmenbrane 
channels formed by the protein mitochondrial (mt) porin make this membrane freely 
permeable to most small molecules (< 4,000 to 5,000 MW). Many proteins are translocated 
into mitochondria in an energy dependent process via the TOM complex in outer membrane 
and the TIM complex in the inner membrane. The inner membrane of mitochondria is less 
permeable and contains more proteins (80 %) than lipids (20 %). The surface area of inner 
membrane is increased by protruding into the matrix forming invaginations called cristae. 
The cristae are the sites where the reactions necessary for generating energy during cellular 
respiration are carried out. Saccharomyces cerevisiae, a facultative anaerobic yeast is an 
excellent model organism to study the mitochondrial enzymes involved in oxidative 
phosphorylation and ATP synthesis. S. cerevisiae can survive in the absence of oxidative 
phosphorylationbecause it possesses the ability of radical alteration of the metabolism 
depending on the availability of a fermentable carbon source. This property of the yeast, S. 
cerevisiae enables an easy detection of the respiratory defective phenotype. 
 
1.1.  The Respiratory Chain 
 
The respiratory chain is localised in the inner mitochondrial membrane and is a configuration 
of four multi-subunit complexes (complex I-IV) that in terms of function are coupled with 
electron transfer and proton pumping. The main function of the respiratory chain is the 
generation of ATP by oxidative phosphorylation (OXPHOS). Electrons are donored to 
respiratory chain from different substrates. While electrons are passed down the chain, 
protons are pumped into the mt intermembrane space, generating thereby a proton gradient 
across the inner membrane, which is the driving force for phosphorylation of ADP to ATP 
catalysed by complex V (for review see Saraste, 1999). Complex I oxidises NADH 
molecules, transfer electrons to ubiquinone (coenzyme Q, CoQ) and pumps protons to the 
IMS. The link between the tricarboxylic acid cycle and the respiratory chain is mediated via 
Complex II. It converts succinate to fumarate, producing reducing equivalents as FADH2 and 
transfering electons to ubiquinone. Ubiquinol:cytochrome c oxidoreductase (bc1 complex or 
complex III) is a central component of the respiratory chain, which transfers electrons from 
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reduced ubiquinone to ferricytochrome c (cyt c) and additional protons are pumped into the 
IMS. Electron flow continues from cyt c through complex IV to molecular oxygen and this 
transfer is also associated with proton uptake into the IMS. Electron flow through OXPHOS 
complexes is schematically shown in Fig. 1.  
S. cerevisiae shows several important differences in the respiratory chain. S. cerevisiae does 
not contain complex I, but instead possesses several NADH dehydrogenases, two of which 
are able to transfer electrons to ubiquinone. Furthermore, a third NADH dehydrogenase is 
present in the outer mitochondrial membrane, which transfers electrons directly to 
cytochrome c. Another difference is that S. cerevisiae contains an enzyme that transfers 
electrons from L-lactate to cyt c, called L-lactate:cytochrome c oxidoreductase or cytochrome 
b2, an enzyme unique to yeast (de Vries and Marres, 1987). 
 
 
Figure 1. Electron flow through the yeast respiratory chain. Electrons (e-) are transfered from two NADH-
dehydrogenases of IM and from Complex II to ubiquinone (Q). Complex III oxidises ubiquinol by transfering e- 
to cytochrome c (Cyt c) in the IMS and pumps protons (H+) into the IMS. Electrons from a third NADH-
dehydrogenase of the OM are transfered directly to Cyt c. Reduced Cyt c gives e- to Complex IV and additional 
H+ are pumped into the IMS. The proton gradient is used by Complex V to produce ATP. Electron flow is 
followed by red arrows and the proton transfer is shown by pink arrows. 
 
A special feature of the respiratory chain is, that from a genetic point of view, it results from 
coordinate expression of the nuclear (n) genome and the mt genome. The mitochondrial DNA 
(mtDNA) of baker`s yeast, S. cerevisiae is 85.8 kb long and encodes subunits I, II and III of 
cytochrome c oxidase (COX1, COX2 and COX3), apocytochrome b (COB), subunits 6, 8 and 
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9 of ATPase (ATP6, ATP8 and ATP9) and a ribosome-associated protein (VAR1). It also 
contains a number of unidentified reading frames (URFs) and intron-related open reading 
frames (ORFs). In addition, the mitochondrial genome specifies the small and large ribosomal 
RNAs (SSU rRNA and LSU rRNA), 24 transfer RNAs (tRNAs) and the 9S RNA (Rpm1r) 
component of RNase P (Foury et al., 1998). All genes are encoded and transcribed from one 
strand, except for tRNAThr1CUN (de Zamaroczy and Bernardi, 1985). 
Formation and assembly of the OXPHOS enzyme complexes require a multitude of specific 
nuclearly encoded proteins. For example, in the case of cytochrome c oxidase (COX or 
complex IV) more than 30 genes have been identified, which are required for specific steps in 
the formation of the enzyme (Pel et al., 1992; Barrientos et al., 2002). Similar factors have 
been reported for ATP synthase and complex III. Factors required for assembly of complex 
III are described later. 
Two models for the molecular organization of the respiratory chain are discussed. In the first, 
components of the respiratory chain are free to diffuse laterally and independently of each 
other in the membrane plane and electron transfer is coupled to diffusion-based collisions 
between the complexes (Gupte et al., 1984). In the other model, respiratory components are 
arranged in macromolecular structures (so called “supracomplexes”) to enhance electron flow. 
Most of the studies favour the second model and indicate that respiratory chain complexes 
form one functional and physical unit (Boumans et al., 1998).  
 
1.2.  Complex III 
 
Enzymes of the cytochrome (cyt) bc1 complex family are central components of all the main 
energy transduction systems of the biosphere, accoording to maintenance of the proton 
gradient and of energy transmission. They all catalyze essentially the same reaction, the 
transfer of reducing equivalents from a quinol in the lipid phase (ubiquinol in the classical bc1 
complexes) to a higher-potential acceptor protein in the aqueous phase. This electron transfer 
is coupled to transfer of 1 H+/e- across the membrane. The mitochondrial complexes arose 
from bacterial antecedents, and the catalytic core of three subunits [cyt c1, cyt b and the 
Rieske iron sulfur protein (ISP)] is highly conserved (Woese, 1987; Degli Esposti et al., 
1993). The latter two subunits span the archaeal/bacterial divide and are clearly more ancient 
than the cyt c1 subunit, whose function is carried by a wide variety of different structures 
(Hunte et al., 2003). 
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1.2.1. The catalytic mechanism of the bc1 complex 
 
The electron (e-) and proton (H+) pathways within the bc1 complex are described by the 
proton-motive Q-cycle mechanism, which was originally proposed by Mitchell (1975). To 
explain the electron and proton pathway in bc1 complex was not so easy, because of one 
putative difficulty: ubiquinol is a 2 e- donor whereas all prosthetic groups of bc1 complex are 
1e- carriers. Already in 1972 Wikstrom and Berden postulated that the electron transfer 
pathway through bc1 complex is not a linear chain, but a branched pathway in which two e- 
from ubiquinol diverge upon its oxidation, one reducing cytochrome b and the other 
cytochrome c1. This idea later on led to Mitchell´s formulation of the Q-cycle mechanism. 
 
1.2.2. The proton motive Q-cycle 
 
An essential feature of the proton motive Q-cycle mechanism is that there are two distinct 
ubiquinone-reaction centers, the Qout and Qin site (Zhu et al., 1982). These sites are located on 
the opposite sites of the membrane and are also called center P or center o, and center N or 
center i, respectively. According to the sequential model of Q-cycle (Fig. 2), ubiquinol (QH2) 
binds to the Qout site of the bc1 complex. After deprotonation the first electron is released to 
reduce the Rieske Fe-S cluster (reaction 1) and is subsequently transferred to cytochrome c1 
(reaction 2) and then to cytochrome c. A rather unstable ubisemiquinone (Q-), formed after 
the first deprotonation, immediately reduces the low potential cytochrome b heme (bL) and a 
second proton is released into the intermembrane space. The electron from bL heme is later on 
transferred to the high potential heme bH (reaction 3) and then reduces ubiquinone at the Qin 
site to form stable ubisemiquinone (reaction 4a). To complete the Q-cycle, another ubiquinol 
must be oxidized on Qout site and the same set of reactions are repeated except the last step. In 
the last step, the Q-cycle is completed by reduction of ubisemiquinone (reaction 4b), which is 
still present at the Qin site to form ubiquinol that can again bind to Qout site. Thus, reaction 1 
occurs twice during one Q cycle, whereas reaction 4b occurs only once. 
Although the mechanism of Q-cycle is generally understood, there is no evidence for a 
semiquinone intermediate at Qout center. Supported with numerous experimental observations 
Trumpower, 2002) has proposed a concerted, alternating sites mechanism of ubiquinol 
oxidation. A concerted mechanism of ubiquinol oxidation is inferred from the finding that 
there is reciprocal control between the high potential and low potential redox components 
involved in ubiquinol oxidation. The potential of the Rieske iron–sulfur protein controls the 
rate of reduction of the b cytochromes, and the potential of the b cytochromes controls the 
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rate of reduction of the Rieske protein and cytochrome c1. The concerted reaction begins 
when ubiquinol binds to His-181 of the Rieske protein, which is one of the ligands to the 
redox active iron of the Fe-S cluster to form a ubiquinol–imidazolate complex. The 
ubiquinol–imidazolate complex then forms a hydrogen bond to Glu-272 of cytochrome b, 
docked within electron transfer distance of the bL heme, so that electrons are transferred from 
the quinol–imidazolate complex to the Rieske cluster and the bL heme simultaneously. As 
cytochrome b is reduced, the hydrogen bond to Glu-272 is broken, allowing the iron–sulfur 
protein to move between cytochromes b and c1. The iron–sulfur protein will remain 
predominately reduced since its potential is higher than that of cytochrome c1. Cytochrome bL 
immediately reduces cytochrome bH, which then reduces ubiquinone to ubisemiquinone at the 
Qin site. The second turnover at center Qout is dependent upon the redox state of cytochrome 
bL and the iron–sulfur protein, and will occur only when both are oxidized (for review see 
Berry and Huang, 2003; Crofts, 2004).  
 
 
Figure 2. The proton motive Q-cycle through the bc1 complex. The electrons from ubiquinol (QH2) are 
released upon deprotonation. One e- is transfered to cytochrome c (Cyt c) via cytochrome c1 (Cyt c1) while the 
second e- reduces the quinone in the first Q-cycle and the ubisemiquinone in the second Q-cycle. Detailed 
description of the Q-cycle reactions (depicted by circled numbers) is in the text. 
 
1.2.3. Relevance of the dimeric structure for catalysis 
 
The catalytic mechanism of the bc1 complex, as described by the Q-cycle, does not consider 
the dimeric structure of this complex. De Vries et al., (1983) proposed a `double Q-cycle´ 
model which incorporates different behavior for each of the two monomers. Linke et al., 
(1986) suggested that dimeric bc1 complex contains only one Qin site and both monomers 
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catalyze single e- transfer at Qout site and co-operate at the Qin site in reducing ubiquinone to 
ubiquinol. A lot of knowledge about the catalytic mechanism of the bc1 complex is derived 
from studies with specific inhibitors. There are numerous inhibitors the bc1 complex that are 
thought to mimic ubiquinol or ubisemiquinone and thus by binding to Qin or Qout sites inhibit 
the enzyme. Some of these inhibitors act with a stoichometry of 0.5 per cytochrome c1, 
indicating that one molecule of inhibitor is sufficient to fully inhibit the dimeric enzyme 
(Gutierrez-Cirlos and Trumpower, 2002). In the same year Trumpower (2002) provided 
evidence for half-of-the-sites reactivity, where only half of the bc1 dimer is active at any one 
time and ubiquinol oxidation alternates between the two halves of the dimer. This mechanism 
is supported by the observation that a crystal structure of the yeast bc1 complex co-
crystallized with cytochrome c shows only one molecule of cytochrome c bound to the 
dimeric enzyme, and ubiquinone is present in only half of the dimer (Lange and Hunte, 2002). 
A mechanism in which only one half of the dimer is active allows for the possibility that, 
under some conditions, both halves of the dimer are active and that the activity of the bc1 
complex may be regulated by switching between a half-of-the-sites active and a fully active 
enzyme. 
 
1.2.4. Structure of the bc1 complex 
 
In the yeast S. cerevisiae complex III is composed of 10 non-identical subunits including the 
catalytic centre composed of cytochrome b (Cobp), cytochrome c1 (Cyt1p) and the Rieske 
FeS protein (Rip1p) (Katan et al., 1976), the two core proteins Cor1p and Cor2p as well as 
five supernumerary subunits (Qcr6p - Qcr10p). All subunits, except for cytochrome b, are 
encoded by nuclear genes. Gene inactivation studies show that the functional bc1 complex 
cannot be formed in the absence of supernumerary subunits except for Qcr10p (Crivellone et 
al., 1988); however the functional roles of these subunits are not well understood. Detailed 
information about the subunits of yeast bc1 complex are summarised in Table 1. 
The crystal structures of cytochrome bc1 complex demonstrate that the enzyme is present as 
an intertwined homodimer (Zhang et al., 1998; Hunte et al., 2000) (Fig. 3). The centre of the 
complex is formed per monomer by eight transmembrane helices of cytochrome b, and 
attached to these central domain are the single transmembrane anchors of the Rieske protein 
and cytochrome c1, the two other catalytic subunits. The extrinsic domains of the latter are 
located in the intermembrane space. On the same side of the membrane, Qcr6p or the so-
called hinge protein is bound. Single transmembrane helices of subunits Qcr8p and Qcr9p are 
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attached at the periphery of the catalytic core. Qcr10p, a loosely associated subunit of the 
yeast complex is not present in the structure (Hunte et al., 2000). The matrix portion of the 
complex is formed by two large subunits, Cor1p and Cor2p, the so-called core proteins, and 
by Qcr7p. The core proteins have high sequence similarity with soluble, matrix processing 
peptidases and are thought to be evolutionarily related to these Zn-binding proteases (Braun 
and Schmitz, 1995). Core proteins do not have proteolytic activity in most species, with the 
exception of plants (Braun and Schmitz, 1995). 
 
Subunit (Synonyms) Molecular weight (MW)1 Prostethic groups 
Cor1p (Qcr1) 
Cor2p (Qcr2) 
Cytbp (COB)* 
Cyt1p (Cytc1) 
Rip1p (Rieske Fe-S) 
Qcr6p 
Qcr7p 
Qcr8p 
Qcr9p 
Qcr10p 
47,4 kDa 
38,7 kDa 
43,6 kDa 
27,8 kDa 
20,1 kDa 
14,4kDa 
14,5 kDa 
10,8 kDa 
7,3 kDa 
8,8 kDa 
- 
- 
b-type hemes (b562 and b566) 
cytochrome c1 
[2Fe-2S] 
- 
- 
- 
- 
- 
Table 1. Subunits of the yeast bc1 complex. The bc1 complex of S. cerevisiae is composed of 10 non-identical 
subunits.  
1 Molecular weights correspond to the mature subunits of the bc1 complex as given by the Yeast Protein 
Database (YPD) (Costanzo et al., 2000).  
* mitochondrially encoded 
 
One of the striking features of the frst bc1 structures was the finding that the extrinsic domain 
of the Rieske protein is mobile. The movement of the Rieske domain facilitates the transfer of 
the iron-sulfur cluster from a position close to heme bL to a position close to heme c1. The 
resulting orientations of the cofactors are well suited for electron transfer and underly the Q 
cycle mechanism and quinol oxidation at Qout site proposed by Trumpower (2002) (see also 
section 1.2.2.). Additionally, there is some evidence that the orientation of the domain is 
related to redox condition (Brugna et al., 2000). 
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Figure 3 Crystal structure of the bc1 complex from yeast mitochondria. The dimeric complex is viewed 
parallel to the plane of the inner membrane (IM) that separates the intermembrane space (IMS) from the matrix 
(MA). Protein subunits are depicted in ribbon representation with respective colors: Cyt c (yellow), Cyt c1 (red), 
cytochrome b (blue), Rip1p (green), Qcr6p (cyan), and Fv fragment (orange). All other subunits are colored in 
gray. Redox cofactors (ball-and-stick representation) are colored in black. The position of the inner membrane is 
indicated as gray boxes. Note that Cyt c (depicted in the frame) is not a subunit of the bc1 complex and only one 
Cyt c molecule is attached to the complex. Figure was adapted from Lange and Hunte (2002). 
 
1.3.  Role of lipids in bc1 complex stability and assembly 
 
Interestingly, phospholipid molecules that are tightly bound within the transmembrane region 
are found in the structure of yeast bc1 complex. Their well-defned binding sites suggest 
specifc roles in assembly and function of the complex (Fig.4). Phospholipids are essential for 
the activity of several membrane proteins (Dowhan, 1997), including complex III (Schagger 
et al., 1990). Increased delipidation of the bc1 complex leads to a gradual decrease in enzyme 
activity up to complete inactivation and destabilization of the complex. A characteristic lipid 
of the inner mitochondrial membrane is cardiolipin, which has been shown to be essential for 
complex III activity (Gomez and Robinson, 1999). Cardiolipin is associated with Cobp and is 
required for the formation of supracomplexes between complexes III and IV (Zhang et al., 
2002). A role of other phospholipids such as phosphatidylethanolamin (PE) in bc1 complex 
dimer formation or phosphatidylinositol (PI) in stabilization of the transmembrane anchor of 
Rip1p and  in stabilization of bc1 complex has been proposed (Lange et al., 2001). 
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Figure 4. Specific, tightly bound phospholipids of the yeast bc1 complex. Binding of phospholipids (yellow) 
and detergent (yellow) in the transmembrane region of bc1 complex viewed from the matrix side on the 
membrane plane. The core of the dimeric complex is made up of eight helices of Cobp (red) per monomer. 
Single helices of Rip1p (green), Cyt1p (yellow), Qcr8p (purple) and Qcr9p (gray) are attached on each side at 
the periphery. The heme b cofactors (light gray) as well as ubiquinone (UQ6) and Stigmatellin (dark gray) are 
shown. The helices are depicted as ribbon drawings, and further molecules as ball-and-stick representation. (PC-
phosphatidylcholin, PI-phosphatidylinositol, PE-phosphatidylethanolamin, CL-cardiolipin) (Lange et. al., 2001) 
 
1.4.  Assembly of the bc1 complex 
 
Components of respiratory electron transfer chain are multi-component complexes, which 
have to assemble both at the right time and in the right place.  
The process of bc1 complex assembly is not fully understood. When centrifuged in a sucrose 
gradient containing 0.1% Triton-X100 and 0.5 M KCl, complex III is split in three distinct 
size fractions, one consisting of Rip1p, the second of Cor1p and Cor2p, and the third of Cobp, 
Cyt1p, Qcr7p and Qcr8p (Crivellone et al., 1988). Zara et al., (2004) analysed the 
composition of cytochrome bc1 subunits in mitochondrial membranes of strains bearing single 
and double deletion mutations in the genes encoding complex III subunits. These data suggest 
that subunits Qcr7p and Qcr8p along with Cobp associate to an 68 kDa subcomplex at an 
early step in the assembly pathway and play an important role in the structural organization of 
the bc1 complex. A second set of subunit interactions is defined by the Cor1p/Cor2p 
subcomplex (84 kDa). Cyt1p has been proposed to be in a subcomplex (58 kDa) with the two 
supernumerary subunits Qcr6p and Qcr9p. In contrast, deletion of the QCR10 gene has no 
effect on the composition of the other bc1 complex subunits and is probably added late in the 
assembly pathway. All these results agree with and extend the model of Berden et al., (1988) 
for the bc1 complex assembly, in which the existence of three distinct subcomplexes is 
proposed. However, it is not known in which order the subunits interact to form the putative 
subcomplexes and in which sequence the subcomplexes are assembled into a functional 
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enzyme. The model of assembly process is schematically shown in Fig. 5. Recently a further 
level of organization for respiratory chain complexes has been reported. The complexes are 
not randomly distributed within the inner mitochondrial membrane, but assemble into 
supramolecular structures. Complex III exists in three forms: the free dimer and two 
supracomplexes comprising in addition one or two complex IV monomers (Schagger and 
Pfeiffer, 2000). Whereas formation of the dimeric forms of complex III and complexes IV 
appears not to be dependent on their ability to form supracomplexes, supracomplex formation 
requires the presence of the assembled bc1 complex and complex IV (Cruciat et al., 2000). 
 
 
Figure 5. Model for bc1 complex assembly. In the first step the formation of three subcomplexes (A, B, C) is 
proposed. However, it is not known in which order the subcomplexes interact to form a functional enzyme. The 
assembly pathway shown in this model is based on the proposal of Geier et al., (1992).  
 
1.4.1. Role of non-subunit proteins (assembly factors of bc1 complex) 
 
Formation and assembly of the OXPHOS enzyme complexes require a multitude of specific 
nuclearly encoded proteins. For example, in the case of cytochrome c oxidase (COX or 
complex IV) more than 30 genes have been identified, which are required for specific steps in 
the formation of the enzyme (Pel et al., 1992; Barrientos et al., 2002). These proteins include 
gene-specific factors for the maturation and translation of COX transcripts, enzymes required 
for the formation and delivery of prosthetic groups, and specific assembly factors (Barrientos 
et al., 2002). Similar factors have been reported for ATP synthase assembly (Ackerman and 
Tzagoloff, 1990) and complex III. In the latter case, gene specific translational activators for 
cytochrome b synthesis (Rödel, 1997) as well as three non-subunit proteins, which are 
important for assembly and/or stability have been detected. Bcs1p is necessary for expression 
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of functional Rip1p and its assembly (as well as of the 8.5 kDa subunit, Qcr10p) into the bc1 
complex (Nobrega et al., 1992; Cruciat et al., 1999). Cbp3p and Cbp4p have been proposed to 
function as enzyme-specific chaperones (Wu and Tzagoloff, 1989; Crivellone, 1994). 
Molecular chaperones mediate the correct folding of target proteins and their assembly into 
oligomeric structures without being components of the final structures (Ellis and van der Vies, 
1991). The proposal that Cbp3p and Cbp4p act as chaperons in complex III formation resulted 
from the observation that mutations in the respective genes lead to the same phenotype, 
namely to loss of bc1 activity accompanied by reduced steady-state levels of Cobp, Rip1p, 
subunit Qcr7p and subunit Qcr8p. The presence of fully processed cytochrome b mRNA and 
its translation in the mutants suggest that Cbp3p and Cbp4p are not involved in an early post-
transcriptional event, but rather in a late stage of complex III assembly (Wu and Tzagoloff, 
1989; Crivellone, 1994). 
 
1.5.  Cbp3 and Cbp4, assembly factors specific for bc1 complex 
 
Cbp3p and Cbp4p homologues have been identified in various eukaryotic organisms. Both 
proteins are members of larger protein family, which plays role in the assembly and/or 
stability of supramolecular enzymes required for electron transport and ATP synthesis (e.g. 
Atp10p, Atp11p, Atp12p, Cox10p, Cox11p, Sco1p).  
Several roles have been proposed for Cbp3p and Cbp4p during enzyme assembly (Crivellone, 
1994). These proteins may interact with and stabilize a selected group of subunits during 
enzyme assembly. The association of subunits into a partially assembled complex could 
provide the binding sites of selected groups of complex III subunits for interaction with other 
subunits of the enzyme. It is also possible that Cbp3p and Cbp4p protect protease labile 
subunits from proteolysis until they assemble. These proteins can mask the interactive sites of 
newly folded subunits, until the correct partner is found. This would prevent unwanted 
interactions with other proteins belonging to other mitochondrial membrane enzymes. 
Both proteins are localised to the mitochondrial membrane. Cbp3p was completely extracted 
into the supernatant following treatment with 0,1 M sodium carbonate (pH=11,7) (Wu and 
Tzagoloff, 1989). This concentration of sodium carbonate does not solubilize integral 
membrane proteins suggesting that Cbp3p is not an integral membrane protein. Upon 
treatment of mitochondria with 0,1 % deoxycholate Cbp3p was detected in the membrane 
fraction (Crivellone, 1994). This concentration of deoxycholate is sufficient to disrupt and 
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release all matrix proteins of the organelle suggesting that Cbp3p is peripherally associated 
with the membrane.  
Cbp4p was not extracted into the supernatant following treatment with 0,1 M sodium 
carbonate (pH=11,5) suggesting that Cbp4p is tightly associated with the membrane 
(Crivellone, 1994). Cbp4p was detected after the treatment of mitochondria with proteinase K 
demonstrating that Cbp4p is not found on the outer surface of the mitochondria (Crivellone, 
1994). 
Cbp4p is a protein with a molecular weight of 20, 313 daltons. The N-terminus exhibits a 
cluster of basic and hydroxylated residues, a common feature of proteins targeted to 
mitochondria (Hartl et al., 1987; Pfanner et al., 1987). The functional domain(s) of the protein 
are in the N-terminus and/or middle regions since the C-terminal 24 residues of Cbp4p are not 
essential for its biological activity (Crivellone, 1994). Swissprot computational analysis 
(Letunic et al., 2004) predicts one transmembrane domain between amino acid (aa) residues 
28-50 and a coiled coil region (124-162 aa). The coiled coil represents a novel functional 
motif in chaperones (e.g. in the AAA + ATPases). They form mechanically rigid structures, 
can undergo dynamic rearrangements by refolding into an alternate structure (e.g. membrane 
fusion proteins) and are encountered as oligomerization domains (leucine zippers). Their 
ability to expose extended surfaces with amphiphilic properties enables them to act as 
scaffolds for protein assemblies. Their exact properties depend on a combination of core 
(hydrophobic) and surface (hydrophilic) residue characteristics (Lupas, 1996a; Lupas, 1996b). 
Cbp3p has a molecular weight of 38 kDa and does not possess any homology to Cbp4p. The 
N-terminal 38 residues of Cbp3p are rich in basic aa, which are generally known to be 
important in mitochondrial import signals. However, deletion mutants of residues ∆12-96 
were respiratory competent, indicating that these residues are not essential for Cbp3p 
function, stability and mitochondrial import (Shi et al., 2001). Three regions essential for 
Cbp3p activity were identified, region 1 (Cys124 through Ala140) and region 3 (Gly223 
through Asp229) were required for Cbp3p function, while region 2 (Leu167 - Pro175) was 
necessary for protein stability. Prediction programs predicted one transmembrane domain 
(148-174 aa) for Cbp3p that overlaps with region 2, which has been shown to be important for 
protein stability (Shi et al., 2001). This region also overlaps Ubiq_cyt_C_chap domain (145-
303) predicted by PFAM program (Letunic et al., 2004). No signal peptide cleavage site in 
both Cbp3p and Cbp4p was predicted. 
Shi et al., (2001) noted that Cbp3p is physically associated with Cbp4p, however 
experimental data for this interaction have not yet been presented. In this respect it is 
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surprising that deletion of CBP3 neither alters the steady state level nor the membrane 
association of Cbp4p (Crivellone, 1994). Possibly mutations in CBP3 and CBP4 affect the 
same step of complex III assembly. This idea is supported by the observation that the 
phenotype of a double mutant resembles that of the single mutants (Crivellone, 1994). 
 
1.6.  BN-PAGE electrophoresis as a new tool to study multi-protein complexes and  
their assembly 
 
In the recent post-genome era a big challenge is to assign a function to each protein and 
describe its relationship to other proteins in the cell. Many proteins assemble into 
multisubunit complexes to fulfill their function and the mitochondrial OXPHOS complexes 
are not an exception. To investigate respiratory chain complexes was a difficult task as they 
are embedded in the mitochondrial inner membrane: too little detergent and the complexes 
would be not released from the membrane, too much and the complexes would dissociate. 
Electrophoresis was also problematical because of high salt concentration used in standard 
purification protocols perturb electrophoresis and additionally, proteins (complexes) need a 
charge to have mobility to move in electric field. The charge usually comes from a chemical 
additive such as SDS, but as SDS is a strong detergent, it causes not only dissociation of 
protein complexes, but also complete denaturation. 
Schägger and von Jagow (1991) elegantly solved these problems by including Serva Blue G 
(Coomassie Blue G250) in the extraction and electrophoresis buffers. Coomassie Blue is 
present during the electrophoresis and binds specifically to the proteins introducing the charge 
similar to SDS without disturbing protein-protein interactions. Protein complexes are 
solubilized with non-ionic detergents like n-dodecylmaltoside, Triton X-100 or digitonin, 
which do not dissociate protein complexes. Extraction of protein complexes was aided by 
inclusion of the zwitterionic salt aminocaprionic acid, which is uncharged at pH 7 and 
therefore does not effect electrophoresis. The technique was named Blue Native 
polyacrylamide gel electrophoresis (BN-PAGE) owing to the color of the crucial compound 
Serva Blue G. 
The separating principle of BN-PAGE is not the charge/mass ratio, but the decreasing pore 
size of the discontinuous polyacrylamide gradient gel, which reduces the protein migration 
velocity according to the mass of the complex and can completely stop protein mobility at the 
mass-specific pore-size limit. BN-PAGE resolves protein complexes approximately between 
100 and 1000 kDa. After the BN-PAGE individual bands are visible and correspond to 
different protein complexes. This facilitates excision of selected bands and recovery of native 
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proteins by electroelution. Individual subunits within these protein complexes can easily be 
analyzed in a second gel dimension in the presence of SDS.   
Since its inception, Blue Native electrophoresis has been adapted to a large number of 
applications that build on the basic principles. The method was standardized for separation of 
complexes between 100-1000 kDa using gradient of 5-13 % acrylamide. Other gradient gels 
may be preferred to focus on a specific complex or subcomplex. For example, a 10-20 % 
gradient gel was employed to resolve protein complexes between 20-200 kDa (Nijtmans et 
al., 1998). Agarose gels are more appropriate for the analysis of complexes higher than 1 
MDa (Henderson et al., 2000). 
Complexes separated by BN-PAGE are still biochemically active as demonstrated in the 
original article (Schagger and von Jagow, 1991). The enzyme activity of complex III after 
extraction from BN-gel was comparable with chromatographically isolated complex III after 
activation with phospholipids. Specific staining methods based on histochemical assays were 
developed to visualize the enzyme activity in the gel (Zerbetto et al., 1997). In-gel activity 
measurements are available for complex I, II, IV and V. Special attention is paid to apply the 
BN-PAGE in investigation the dynamics of complex assembly. The dynamics of protein 
synthesis and complex assembly can be addressed using BN/SDS-polyacrylamide 2D 
electrophoresis in combination with pulse chase labeling of proteins in cultured cells 
(Nijtmans et al., 2002b). 
Recent development in biology is high-throughput mass spectrometry (MS) (Mann et al., 
2001). This technique is very sensitive and allows a rapid identification of a spot on the gel. 
Combination of MS together with BN-PAGE either with or without a second dimension SDS-
PAGE represents a very powerful tool to study protein complexes and their composition. 
Although Blue Native electrophoresis was developed in 1991 it was only few years ago 
before other groups discovered many benefits of the method. These days BN-PAGE is 
employed in many laboratories in studying membrane-bound complexes. It is expected that 
the use of BN-PAGE will increase as it can be set up easily and has a wide range of 
applications. Additionally, the use of BN-PAGE is not restricted only to study the membrane-
bound complexes, but can be applied in a proteomics approach for identification and analysis 
of multi-protein complexes required their separation under native conditions as for example 
used to identify protein complexes from whole cellular lysates (Camacho-Carvajal et al., 
2004). 
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2. MATERIALS AND METHODS 
 
2.1.  MATERIALS 
 
2.1.1. Instruments 
 
LI-COR DNA sequencer (model 4000/4200)  MWG-BIOTECH 
French Press       SLM-AMINCO 
Dounce homogeniser      BRAUN 
 
2.1.2. Materials 
 
Acrylamide/Bisacrylamide    SIGMA 
Antimycin A      SIGMA 
BenchMarkTM Prestained    INVITROGEN 
Calmodulin Affinity Resin    STRATAGENE 
Coenzyme Q10     SIGMA 
CombiZym DNA Polymerase   InViTek 
Complete EDTA-free (Protease inhibitor cocktail) ROCHE 
Coomassie  Brilliant Blue G250   MERCK 
Cytochrome c      SIGMA 
Digitonin      SIGMA 
Dithiothreitol      SIGMA 
dNTPs       GIBCO-BRL/INVITROGEN 
DSP       PIERCE 
ECLplus-SystemTM     AMERSHAM PHARMACIA BIOTECH 
Gel Blotting Paper     SCHLEICHER & SCHUELL 
Herring Sperm DNA     INVITROGEN 
ImmobilonTM-P PVDF-Membrane   MILLIPORE 
λ-DNA EcoRI/HindIII    GIBCO-BRL 
Maltoside      SIGMA 
PMSF       SIGMA 
Primers      MWG-BIOTECH 
Protein A-Agarose     SANTA CRUZ BIOTECHNOLOGY 
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Proteinase K      ROTH 
Rabbit IgG Agaraose     SIGMA 
Restriction Enzymes     GIBCO-BRL 
Rotiphorese  Gel 30     ROTH 
Seakem  LE Agarose     CAMBREX 
Taq DNA Polymerase    INVITROGEN 
T4-DNA-Ligase     PROMEGA 
TEMED      GIBCO-BRL 
Triton X-100      ROCHE 
Tween 20      ROTH 
X-ray films      AMERSHAM PHARMACIA BIOTECH 
Zymolyase 20T     ICN 
 
2.1.3. Kits 
 
DC-Protein Assay     BIO-RAD 
NucleoSpin® Extract     MACHEREY-NAGEL 
NucleoSpin® Plasmid Quick Pure   MACHEREY-NAGEL 
Thermo-Sequenase fluorescent labeled  AMERSHAM PHARMACIA BIOTECH 
primer cycle sequencing kit with 7-deaza-dGTP 
Wizard® SV Gel and PCR Clean-Up System PROMEGA 
 
2.1.4. Antibodies 
 
Dilution in 1x TBS-T with 5 % 
(w/v) skimmed milk powder 
 
Rabbit-Anti-yAco1p (kindly provided by R. Lill, Marburg) 1:2000 
Rabbit-Anti-yCyt1p (Zollner et al., 1992)    1:1000 
Rabbit-Anti-yCytb2 (Krummeck, 1992)    1:2000 
Mouse-Anti-yCox3p (MOLECULAR PROBES)   1:1000 
Mouse-Anti-Pgk1p (MOLECULAR PROBES)   1:1000 
Mouse-Anti-Porin (MOLECULAR PROBES)   1:1000 
Mouse-Anti-EGFP (ROCHE)     1:1000 
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Mouse-Anti-HA (ROCHE)      1:1000 
Mouse-Anti-CMYC (ROCHE)     1:400 
Rabbit-Anti-yRip1p (kindly provided by R. Lill, Marburg)  1:2000 
Rabbit-Anti-TAP (OPEN BIOSYSTEMS)    1:2000 
Rabbit-Anti-goat IgG-HRP (DAKO A/S)    1:2000 
Rabbit-Anti-ySco1p (Buchwald et al., 1991)   1:3000 
Sheep-Anti-mouse IgG-HRP (AMERSHAM    1:5000 
PHARMACIA BIOTECH) 
Donkey-Anti-rabbit IgG-HRP (AMERSHAM    1:5000 
PHARMACIA BIOTECH) 
 
2.1.5. Strains 
 
2.1.5.1.  Escherichia coli (E.coli) 
 
Strain Genotype Reference 
DH5α φ80dlacZ∆M15, recA, endA1, gyrA96, thi-1, hsdR17(rK-, 
mK-), supE44, relA1, deoR, ∆(lacZYA-argF)U169 
Hanahan (1983) 
XL10 Gold Tetr ∆(mcrA)183 ∆(mcrCB-hsdSMR-mrr)173 endA1, 
supE44, thi-1, recA1, gyrA96, relA1, lac Hte [F´proAB 
lacIq Z∆M15 Tn10(Tetr) Amy Camr]a 
STRATAGENE 
 
 
2.1.5.2.  Saccharomyces cerevisae (S. cerevisae) 
 
Strain Genotype Reference 
BY4741 MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0 Euroscarf 
accession Y00000 
cbp3∆ MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0; cbp3::kanMX4 Euroscarf 
accession Y01077 
cbp3∆ MAT α; his3∆1; leu2∆0; lys2∆0; ura3∆0; cbp3::kanMX4 Euroscarf 
accession Y11077 
cbp3∆−COR1-
TAP 
MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0; 
cbp3::kanMX4, COR1:: (COR1-TAP-URA3-KL) 
this work 
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cbp4∆ MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0; cbp4::kanMX4 Euroscarf 
accession Y04804 
cbp4∆ MAT α; his3∆1; leu2∆0; lys2∆0; ura3∆0; cbp4::kanMX4 Euroscarf 
accession Y14804 
cbp4∆−COR1-
TAP 
MAT α; his3∆1; leu2∆0; lys2∆0; ura3∆0; cbp4::kanMX4, 
COR1:: (COR1-TAP-URA3-KL) 
this work 
bcs1∆ MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0; bcs1::kanMX4 Euroscarf 
accession Y04211 
cyt1∆ MAT a; his3∆1; leu2∆0; lys2∆0; ura3∆0; cyt1::kanMX4 Euroscarf 
accession Y11841 
10000M MAT a; ura3-52; leu2∆1; trp1∆63; his3∆200; GAL2 Euroscarf 
accession 10000M 
crd1∆ MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0; 
YDL142c::kanMX4 
Euroscarf 
accession Y03840 
taz1∆ MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0; 
YDL140w::kanMX4 
Euroscarf 
accession Y05555 
KL14-4A MATa, his1, trp2, [rho0] Wolf et al. (1973) 
IL993-5c MATα, ilV5, [rho0] Wolf et al. (1973) 
fyv5∆ MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0; fyv5::kanMX4 Euroscarf 
accession Y06877 
yar069∆ MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0; yar069:: URA3 this work 
ZK1 MAT a; ura3-52; leu2∆0; trp1∆63; his3∆200; GAL2, 
CBP3:: (CBP3-HA-Sphis5+), CBP4::(CBP4-cMyc-TRP1) 
this work 
ZK1-B MATα; ura3-52; leu2∆0; trp1∆63; his3∆200; GAL2, 
CBP3:: (CBP3-cMyc-TRP1), CBP4::(CBP4-HA-Sphis5+) 
this work 
ZK2 MAT a; his3∆1; leu2∆0; met15∆0; ura3∆0, CBP3:: 
(CBP3-TAP-URA3-KL), CBP4::(CBP4-cMyc-HIS3) 
this work 
ZK3 MAT a; ura3-52; leu2∆0; trp1∆63; his3∆200; GAL2, 
CBP3:: (CBP3-HA-Sphis5+), CBP4::(CBP4-cMyc-TRP1), 
COR1:: (COR1-TAP-URA3-KL) 
this work 
ZK4 MAT a/α; ura3-52/ura3-52; leu2∆0/leu2∆0; 
trp1∆63/trp1∆63; his3∆200/his3∆200; GAL2/GAL2, 
CBP4:: (CBP4-cMyc-TRP1)/CBP4:: (CBP4-HA-URA3) 
this work 
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ZK5 MAT a/α; ura3-52/ura3-52; leu2∆0/leu2∆0; 
trp1∆63/trp1∆63; his3∆200/his3∆200; GAL2/GAL2, 
CBP3:: (CBP3-cMyc-TRP1)/CBP3:: (CBP3-HA-URA3) 
this work 
ZK5-B MAT a/α; his3∆1/HIS3; leu2∆0/leu2∆0; met15∆0/MET15; 
TRP1/trp1∆63; ura3∆0/URA3, GAL2/GAL2, CBP3:: 
(CBP3-TAP-URA3-KL)/(CBP3-cMyc-TRP1) 
this work 
QCR7-TAP MAT a his3∆1; leu2∆0; met15∆0; ura3∆0, QCR7:: 
(QCR7-TAP-tag-HIS3MX6) 
Open Biosystems 
YSC1178-7501236 
QCR8-TAP MAT a his3∆1; leu2∆0; met15∆0; ura3∆0, QCR8:: 
(QCR8-TAP-tag-HIS3MX6) 
Open Biosystems 
YSC1178-7500107 
 
2.1.5.3.  Schizosaccharomyces pombe (S. pombe) 
 
Strain Genotype Reference 
KO 105 h -S  ura4-D18 K. Ostremann, Dresden 
 
2.1.6. Media  
 
LB      1,0 % (w/v) Tryptone  
      0,5 % (w/v)Yeast extract 
      0,5 % (w/v) NaCl  
      2,0 % (w/v) Agar (for LB-Plates) 
 
YP-       1 % (w/v)Yeast extract  
2 % (w/v) Peptone  
2 % (w/v) Glucose, Raffinose, Galactose 
or 
3 % (w/v) Glycerin  
      2,0 % (w/v) Agar (for YP-Plates) 
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WO      1,7 g/l Yeast nitrogen base 
      5,0 g/l Ammonium sulphate 
      2,0 % (w/v)Glucose 
      2,0 % (w/v) Agar (for MM-Plates) 
      Amino acids / Nucleotide (see Table 2) 
 
Amino acid/ 
nucleotide 
Final concentration 
L-Histidine 60 mg/l 
L-Leucin 80 mg/l 
L-Lysin 30 mg/l 
L-Methionine 20 mg/l 
Uracil 30 mg/l 
L-Tryptophane 80 mg/l 
Table 2. Amino acids and nucleotide used for minimal medium. According to the auxotrophic markers of 
used strains, the above listed amino acids and nucleotides were added to minimal medium in the respective final 
concentration. 
 
Lactate Medium     22,0 ml/l Lactate (90 %)  
1,0 g/l Glucose  
3,0 g/l Yeast extract  
1,0 g/l KH2PO4  
1,0 g/l NH4Cl  
0,5 g/l CaCl2 x H2O  
0,6 g/l MgCl2 x 2H2O  
0,5 g/l NaCl  
8,0 g/l NaOH  
 
Add distilled H2O to 1 l and set the pH with NaOH to 5,5. 
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2.1.7. Buffers 
 
TBE       90 mM Tris 
       90 mM Boric acid 
       2,5 mM EDTA 
 
TBS       137 mM NaCl 
       20 mM Tris-HCl (pH 7,4) 
 
TBS-T       1 x TBS 
       0,1 % (v/v) Tween 20 
 
2.1.7.1. Buffers and Solutions for SDS-PAGE 
 
Running gel (10% or 12%)    375 mM Tris-HCl, pH 8,8 
       10 % or 12 % (w/v) Acrylamide 
       0,32 % Bisacrylamide 
       0,1 % (w/v) SDS 
       0,1 % (w/v) Ammonium persulphate 
       0,1 % (v/v) TEMED 
 
Stacking gel       125 mM Tris-HCl, pH 6,8 
       4 % (w/v) Acrylamide 
       0,1 % Bisacrylamide 
       0,1 % (w/v) SDS 
       0,1 % (w/v) Ammonium persulphate 
       0,1 % (v/v) TEMED 
 
Running buffer     25 mM Tris 
       192 mM Glycin 
       0,1 % (w/v) SDS 
 
6 x loading buffer     300 mM Tris-HCl, pH 6,8 
       30 % (w/v) Glycerol 
10 % (w/v) SDS 
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       0,1 % (w/v) Bromphenol Blue 
       600 mM DTT or 5 % β-mercaptoethanol 
       (freshly added) 
 
Coomassie blue staining    45 % (v/v) Methanol 
       17 % (v/v) Acetic acid 
       0,1% (w/v) Coomassie brilliant blue G250 
 
Destaining solution     30 % (v/v) Methanol 
       7 % (v/v) Acetic acid 
 
2.1.7.2. Buffers and Solutions for Western blot 
 
Transfer buffer     192 mM Glycine 
       25 mM Tris  
       5,0 % (v/v) Methanol 
       0,1 % (w/v) SDS 
 
Ponceau S staining     0,5 % (w/v) Ponceau S 
       1,0 % (v/v) Acetic acid 
 
Blocking solution     TBS-T 
       5 % (w/v) skimmed milk powder 
 
2.1.7.3. Buffers and Solutions for isolation of yeast mitochondria 
 
MTE       1,8 m M KH2PO4, pH 7,3 
0,65 M Mannitol 
20 mM Tris-HCl, pH 7,1 
1 mM EDTA 
1 mM  PMSF (freshly added) 
 
Buffer A      0,1 M Tris/SO4, pH 9,4 
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Buffer B      1,2 M Sorbitol 
       20 mM KH2PO4, pH 7,4 
 
Buffer C      1,2 M Sorbitol 
 
Buffer D      0,65 M Mannitol 
10 mM Tris-HCl, pH 7,4 
 
2.1.7.4. Buffers and Solutions for BN-PAGE 
 
Gel buffer      1,5 M Aminocaproic acid 
       150 mM Bis-Tris 
 
Kathode buffer A     7,5 mM Imidazol 
       50 mM Tricine 
       0,02 % (w/v) Serva Blue G-250 
 
Kathode buffer B     7,5 mM Imidazol 
       50 mM Tricine 
       0,002 % (w/v) Serva Blue G-250 
 
Anode buffer      25 mM Imidazol 
 
Solubilization solution    50 mM NaCl 
       5 mM Aminocaproic acid 
       50 mM Imidazol 
 
Denaturation solution     1 % (w/v) SDS 
       1 % β-mercaptoethanol 
 
2.1.7.5. Buffers and Solutions for Co-immunoprecipitation 
 
Lysis buffer I      50 mM Tris-HCl, pH 7,6 
       150 mM NaCl 
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       1% (w/v) Detergent 
       2 mM DTT 
       1 mM EDTA 
       1 mM PMSF 
       1 x PI-Mix 
 
Buffer for crosslinking    50 mM HEPES, pH 7,9 
       150 mM NaCl 
       0,6 M Sorbitol 
1 mM PMSF 
       1 x PI-Mix 
 
Quenching buffer     1 M Tris-HCl, pH 8,0 
 
Washing buffer after crosslinking   50 mM HEPES, pH 7,9 
       0,6 M Sorbitol 
1 mM PMSF 
       1 x PI-Mix 
 
Solubilization buffer     50 mM HEPES, pH 7,9 
       150 mM Potassium acetate 
       2 mM Magnesium acetate 
       2 mM ATP 
1 mM PMSF 
       1 x PI-Mix 
 
2.1.7.6. Buffers and Solutions for TAP 
 
IPP150- buffer     10 mM Tris-HCl, pH 8,0 
       150 mM NaCl 
       0,1 % (w/v) Detergent (Triton X-100) 
 
TEV-buffer      10 mM Tris-HCl, pH 8,0 
       150 mM NaCl 
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       0,1 % (w/v) Detergent (Triton X-100) 
       0,5 mM EDTA 
       1 mM DTT 
 
Calmodulin binding buffer    10 mM β-mercaptoethanol 
10 mM Tris-HCl, pH 8,0 
       150 mM NaCl 
       1 mM Magnesium acetate 
       1 mM Imidazol 
       2 mM CaCl2 
       0,1 % (w/v) Detergent (Triton X-100) 
 
Calmodulin elution buffer    10 mM β-mercaptoethanol 
10 mM Tris-HCl, pH 8,0 
       150 mM NaCl 
       1 mM Magnesium acetate 
       1 mM Imidazol 
       2 mM EGTA  
       0,1 % (w/v) Detergent (Triton X-100) 
 
2.1.8. Vectors 
 
Vector Genetic marker Reference 
p416 ADH Ampr, URA3, CEN-ARS, ADH-promoter Mumberg et al. (1995) 
p426 ADH Ampr, URA3, 2-micron, ADH-promoter Mumberg et al. (1995) 
p426 GPD Ampr, URA3, 2-micron, GPD-promoter Mumberg et al. (1995) 
pBS1539 Ampr, URA3-KL, CoIE1 origin Rigaut et al. (1999) 
puZV 108 Ampr, HA3-HISMX, lacZ´ W. Zacharie, Dresden 
puZV 89 Ampr, HA3-TRP1-KL lacZ´ W. Zacharie, Dresden 
puZV 87 Ampr, MYC9-TRP1-KL lacZ´ W. Zacharie, Dresden 
pGA 2254 Ampr, MYC9- HISMX, lacZ´ W. Zacharie, Dresden 
pTG9 Ampr, GFP-ura4+, nmt1 K. Ostremann, Dresden 
 
 
Materials and Methods 
 29 
2.1.9. Primers 
 
Primer Sequence (5´to 3´) Enzyme site 
CBP3-HA-c-myc 
for 
TTA CCA AGC GAG AGA AGT AGG CTG TCA TAT 
ACA AAC TCC GGT TCT GCT GCT AG 
 
CBP3-HA-c-myc 
rev 
TGT GCG GAT AGT ATC TGA AGA ATA AAT AAG 
TGT TTT CAT AAG CCT CGA GGC CAG AAG AC 
 
CBP3-HA-myc 
check for 
GCC ACA GGT AAA TTC AAG TTT G 
 
 
CBP4-HA-c-myc 
for 
ATA GTC CAG GAT AAG CAG GTT AAA AGC TGG TGG 
CGC TTC TGG TCC GGT TCT GCT GCT AG 
 
CBP4-HA-c-myc 
rev 
ATG ACA CAG ACG TAT GTT TTA GGA TGC AAA AGT 
TCA AGC TGC CCT CGA GGC CAG AAG AC 
 
CBP4 ORF for TAT TAT GGA TCC ATG CAG TGC GCG ATA ACT CC  
CBP4 ORF rev TAT TAT GAA TTC CTA CCA GAA GCG CCA CCA GC  
CBP3-TAP for CCT AAA ACC TTA CCA AGC GAG AGA AGT AGG CTG 
TCA TAT ACA AAC TCC ATG GAA AAG AGA AG 
 
CBP3-TAP rev TGT GCG GAT AGT ATC TGA AGA ATA AAT AAG TGT 
TTT CAT AAG TAC GAC TCA CTA TAG GG 
 
CBP3-TAP check GAG GAA ATG AAA GTT AAT TCT GG  
COR1-TAP for TTA TTA GAT TAC ATG AGA ATC AGA AGT GAC ATG 
TCC ATG ATG AGA TGG TCC ATG GAA AAG AGA AG 
 
COR1-TAP rev CAT TTA TGG TGT GAG TGT GCG AGC GTG CCT GTA 
TAC ATC TAG CAG CTT TAC GAC TCA CTA TAG GG 
 
COR1-TAP check AAG AGA TTA TGG GAC  
URA3KLfor GCA GGT GGC TAT TAG  
URA3KLrev ATG GTC TGA TAT CAC  
HISfor CAA GTA GAC ACG GGA ATT GG  
HISrev TTT CAG CAC GAT GAT GGG TC  
YAR1 for ACA GTC GGT CGG ATA ATA TCT CCT TCC AAC AGT 
AGG AGA CGT ACG CTG CAG GTC GAC 
 
YAR1 rev AAG ACT CGA CAA TAC AAT TTT CTT ATA CTA AAC 
GTA GAT ATC GAT GAA TTC GAG CTC G 
 
YAR check for GAA CTA CAG AAT GTT ATG CG  
YAR check rev GCC CAC ACG ATT CCT GTG CAA AG  
ScCBP3 for TAT TTA CTG CAG CCA ACA CTT GAT GAT GTC AGT PstI 
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CAA TAG 
ScCBP3 rev AAA TAT ATC GAT GCT CGT TTA GTT TGT ATA TGA 
CAG CC 
ClaI 
ScCBP3-HindIII 
for 
TAT TAT AAG CTT CAC TTG ATG ATG TCA GTC AAT AG HindIII 
CMYC rev TAT TAT ATC GAT GTT CAA GTC TTC TTC TGA GAT 
TAA  
ClaI 
SpCBP3 for TAT TAT TCT AGA ATG AGT CGC TGC TGT TTA AAT 
TTG CC 
XbaI 
SpCBP3 rev TAT TAT ATC GAT TCA AAT ATT TGT TTG TGC ACT TTC 
TTC AGG 
ClaI 
SpCBP3-GFP for TAT TAT GAG CTC AAA TGA GTC GCT GCT GTT TAA 
ATT TG 
SacI 
SpCBP3-GFP rev TAT TAT CTG CAG AAA TAT TTG TTT GTG CAC TTT CTT 
C  
PstI 
HsCBP3 for TTA TTA ATC GAT ATG GCG TTG CTG GTG CGA GTC ClaI 
HsCBP3 rev TAT ATA CTC GAG AGC CCA TCA AAG TCC CTC GTC XhoI 
CP1 for  CAT CTG AAT TCG AAA CCT CAA GAT CCA CGT  
CP1 rev ACG TGG ATG TTG AGG TTT CGA ATT CAG ATG  
CP2 for CAC TTC GTC CCA CCT GGG GTG AAG GTC GAA  
CP2 rev TTC GAC CTT CAC CCC AGG TGG GAC GAA GTG  
C4 for GAT GTT CAG CAG CGC TTA TTC GAG GAA ATG AAA  
C4 rev  TTT CAT TTC CTC GAA TAA GCG CTG CTG AAC ATC  
C5 for  GAC ATT GAG CTG AGA GGC AGA GTC ATG GGG  
C5 rev  CCC CAT GAC TCT GCC TCT CAG CTC AAT GTC  
EGFP-for * CTG GTT TAG TGA ACC GTC AG  
EGFP-rev * ACG CTG AAC TTG TGG CCG TT  
uni-21 * TGT AAA ACG ACG GCC AGT  
rev-29 * CAG GAA ACA GCT ATG ACC  
Table 3. Primers used for the plasmids construction, integrations cassettes construction and for 
sequencing. The enzyme recognition sites are indicated in italic. Primers used for construction of integrations 
cassettes for HA-, CMYC- and TAP-tagging and sequences of anneling regions are in bold. (*) indicates 5` 
IRD800 labelled sequencing primers. 
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2.1.10. Recombinant plasmids 
 
Here are listed recombinant plasmids constructed in this work. The names of the plasmids are 
indicated on the left and the resulting protein or gene on the right. The numbers in brackets 
indicate aminoacid positions. (/) indicates the switch between two genes. P = Promoter 
 
Plasmid Insert 
ScCBP3-p416ADH ADH1-P, ScCBP3-ORF 
SpCBP3-p416ADH ADH1-P, SpCBP3-ORF 
HsCBP3-p416ADH ADH1-P, HsCBP3-ORF 
SpCBP3-GFP-pTG9 NMT1-P, SpCBP3-GFP Fusion 
CHP1-p416ADH ADH1-P, ORF ScCbp3p(1-58)/SpCbp3p(59-291)/ ScCbp3p(292-
337), Fig. 9 
CHP2-p416ADH ADH1-P, ORF ScCbp3p(1-58)/SpCbp3p(58-301), Fig. 9 
HC1-p416ADH ADH1-P, ORF ScCbp3p(1-144)/HsCbp3p(145-291)/ 
ScCbp3p(292-337), Fig. 10 
HC2-p416ADH ADH1-P, ORF ScCbp3p(1-144)/HsCbp3p(145-246)/ 
ScCbp3p(247-337), Fig. 10 
HC3-p416ADH ADH1-P, ORF ScCbp3p(1-144)/HsCbp3p(145-198)/ 
ScCbp3p(199-337), Fig. 10 
HC4-p416ADH ADH1-P, ORF ScCbp3p(1-198)/HsCbp3p(199-246)/ 
ScCbp3p(247-337), Fig. 10 
HC5-p416ADH ADH1-P, ORF ScCbp3p(1-198)/HsCbp3p(199-291)/ 
ScCbp3p(292-337), Fig. 10 
CBP3-CMYC-p416ADH ADH1-P, CBP3-CMYC Fusion 
CBP4-CMYC-p416ADH ADH1-P, CBP4-CMYC Fusion 
CBP3-CMYC-p426ADH ADH1-P, CBP3-CMYC Fusion 
CBP4-CMYC-p426ADH ADH1-P, CBP4-CMYC Fusion 
CBP3-CMYC-p426GPD GPD1-P, CBP3-CMYC Fusion 
CBP4-CMYC-p426GPD GPD1-P, CBP4-CMYC Fusion 
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2.2.  Methods 
 
2.2.1. Amplification of DNA by Polymerase Chain Reaction (PCR) 
 
Standard PCR 
 
The CBP3 gene of S. cerevisiae, S. pombe and human were amplified from genomic DNA by 
standard PCR. Respective PCR products were subsequently cloned into an appropriate vector 
as indicated in the result part. The oligonucleotide primers are listed in section 2.1.9. The 
anneling temperature for PCR reaction was calculated according to the following formula 
(MWG-BIOTECH): 
 
Ta = 69,4°C + 0,41 x (GC-Percent) – 650/ Primer length - 6°C 
 
The following mix was used : 
Components Final concentration 
PCR-Buffer (10x) 1 x 
Template (x ng/µl) 1 ng/µl 
dNTP Mix (each dNTP 10 mM) 0,2 mM 
forward-Primer (100 pmol/µl) 1,5 pmol/µl 
reverse-Primer (100 pmol/µl) 1,5 pmol/µl 
DNA Polymerase (5 U/µl) 2,5 U 
Total volume (H2O upto:) 100 µl 
 
Following programe was used for DNA amplification: 
General PCR 
 
5 min 95°C Initial denaturation 1x 
1 min 94°C 
1 min Ta 
2 min 72°C 
Denaturation 
Annealing 
Elongation 
 
20x 
5 min 72°C Final Elongation 1x 
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Overlap Extension PCR (Pogulis et al., 1996) 
 
By using the overlap extension PCR one can fuse DNA fragments without using the 
restriction and/or ligation procedure. Overlap PCR was used to construct different chimeras 
between the CBP3 gene of S. cerevisiae and S. pombe or human, respectively. Primers used 
for overlapping PCR contain about 20 bp overlapping region to the part coming from another 
sequence and are listed in section 2.1.9 (CP1-2 and C4-5). The respective sub-fragments of 
the genes were amplified by general PCR. Purified sub-fragments served as templates for 
amplification of further product consisting of all parts used in the reaction yielding the final 
fused gene product. The annealing temperature was calculated from the flanking primers not 
overcoming the annealing temperature of overlapping regions of the sub-fragments. Obtained 
chimeras were cloned into vector p416ADH. 
 
Following cycles were used: 
5 min 95°C Initial denaturation 1x 
1 min 94°C 
1 min Ta 
2 min 72°C 
Denaturation 
Annealing 
Elongation 
 
10x 
1 min 94°C 
1 min Ta + 5°C 
2 min 72°C 
Denaturation 
Annealing 
Elongation 
 
20x 
5 min 72°C Final Elongation 1x 
 
2.2.2. Analysis of DNA 
 
Standard techniques were used for restriction endonuclease analysis of DNA, ligation of DNA 
fragments, transformations and recovery of plasmid DNA from E. coli (Sambrook et al., 
1989). Purification of PCR products and plasmids was carried out with the kits listed in 
section 2.1.3 according to the instructions of the manufacturers. 
 
2.2.3. Sequencing 
 
DNA sequences were determined by the dideoxy chain determination method of Sanger 
(Sanger et al., 1977) using 5´IRD800-labelled primers and the Thermo Sequenase fluorescent 
labelled primer cycle sequencing kit with 7-deaza-dGTP as described by the manufacturer and 
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the LI-COR DNA sequencer. Primers for sequencing are listed in Table 3. The annealing 
temperature of the primers was calculated according the following formula (MWG-
BIOTECH): 
 
Ta = 69,4°C + 0,41 x (GC-Percent) – 650/ Primer length + 3°C 
 
2.2.4. Transformation of yeast 
 
Yeast cells were transformed using the LiAc procedure (Gietz et al., 1995) 
 
2.2.5. Isolation of yeast mitochondria 
 
2.2.5.1. Mechanical Isolation of yeast mitochondria (quick method) 
 
Yeast cells were grown to stationary phase in an appropriate medium. Cells were harvested by 
centrigugation at 3000 x g for 5 minutes. After washing with 1ml ice-chilled water, cells were 
resuspended in 0,5 ml ice-chilled MTE buffer. Lysis of cells was performed by vigorous 
vortexing for 5 minutes in the presence of 400 µl glass beads (∅  0,45 mm). Supernatants were 
collected to new tubes and glass beads were washed with 0,5 ml ice-cold MTE. The 
supernatants of the washing step were added to the previous supernatants. Unbroken cells and 
cell debris were removed by centrigugation at 3000 x g for 3 min at 4°C. Mitochondria were 
pelleted by centrifugation at 13 000 x g for 20 min at 4°C. Mitochondria were resuspended in 
the 50-100 µl MTE and stored at – 80°C. 
 
2.2.5.2. Enzymatical Isolation of yeast mitochondria (long method) 
Daum et al. (1982) 
 
Yeast cells were grown to stationary phase in an appropriate medium. Cells were harvested by 
centrigugation at 3000 x g for 5 minutes. After washing with 1 ml water, cells were 
resuspended in WCW/0,5 = …ml buffer A (WCW- wet cell weight). To the cell suspension 
1,54 mg DTT per 1 ml of buffer A was added and incubated 10 min by 30°C. The cells after 
harvesting (3000 x g, RT, 5 min) were washed in ca. 30 ml of buffer C and resuspended in 
WCW/0,15 = …ml buffer B. 2 mg of Zymolyase 20T per 1g of WCW was added and 
incubated 30-60 min at 30°C. Control of spheroplasting was performed by measuring the 
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OD600. 10 µl of cell suspension before Zymolyase 20T treatment were resuspended in 1 ml of 
watter. Spheroplasting was controlled every 15 min. The following steps were performed on 
ice (4°C), buffers D and C were ice-chilled. Spheroplasts were harvested (3000 x g, RT, 5 
min) and washed once with buffer C. Spheroplasts were resuspended in ca. 10 ml of buffer D, 
1 mM PMSF, freshly added. Spheroplasts were 3x homogenised in Dounce-Homogenisator 
(15 ml, Wheaton, USA) always in 10 ml buffer D. Lysates were collected in the 
centrifugation tubes. The rest of the cells was separated from the lysate by centrifugation 
(3000 x g, RT, 5 min.). Supernatants were collected and pellets again pottered. After the last 
pottering the Dounce-Homogenisator was washed with buffer D. Collected supernatants were 
centrifuged 10 min, 12000 x g, 4°C. Pellets were washed once with ca. 30 ml buffer D 
(+1mM PMSF) and again the rest of cell fragments were separated by 3000 x g, 5 min, 4°C 
centrifugation. Mitochondria were pelleted by 12000 x g, 10 min, 4°C centrifugation step, 
resuspended in the 100-300 µl buffer D and stored at – 80°C. 
 
2.2.6. Solubilization of mitochondria 
 
In principle, any neutral detergent can be used for the solubilization of biological membranes 
if the detergent can solubilize the desired protein and keep it in the native state. We 
preferentially use Triton X-100, digitonin and dodecyl-β-D-maltosid, all of which are stored 
as 10 % stock solutions. Triton X-100 and dodecyl-β-D-maltosid/protein ratio of 2-3 g/g is 
required for solubilization of mitochondrial membranes. Using digitonin, the 
detergent/protein ratio is doubled to 4-6 g/g, respectively. The most suitable detergent/protein 
ratio is equilibrated for each studied protein complex. 50-500 µg of total protein from isolated 
mitochondria are resuspended in the lysis buffer and the detergent is added in the required 
concentration. Solubilization is complete within 10-20 min incubation on ice. The sample is 
then centrifuged for 20 min at 20 000 x g. Solubilized protein complexes are in the 
supernatant. 
 
2.2.7. Immunoprecipitation 
 
Immunoprecipitation of mitochondrial proteins was performed with anti-HA and anti-cMyc 
antibodies. 50 µl protein A-Sepharose beads were incubated with antibodies for 2 h at  4°C on 
an orbital shaker. 500 µg mitochondria were lysed as described in section 2.7 and the 
supernatant was incubated with the protein A-Sepharose beads for 4h at 4°C. Beads were 
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washed 3-4 times with 1 ml lysis buffer. Immunoprecipitates were examined by Western blot 
analysis. 
 
2.2.8. Western blot analysis 
 
Proteins were separated on 10 % or 12 % polyacrylamide gels in the presence of SDS. 
Proteins were transferred to a PVDF membrane using the semi-dry method for 1h at RT at 1,5 
mA/cm2. Membranes were blocked at least 1h at RT or over night at 4°C with 5 % (w/v) non-
fat dry milk in TBS-T. Membranes were probed with polyclonal or monoclonal antisera for 
1h at RT and then washed three times for 10 minutes in TBS-T. Horseradish peroxidase-
conjugated anti-rabbit or anti-mouse antibodies were used as secondary antibodies. The 
secondary antibody was added to the membranes for 30 min at RT. Before the antigen-
antibody complexes were visualised by enhanced chemiluminiscence (ECL plus), the 
membranes were washed three times for 10 minutes in TBS-T. 
 
2.2.9. Blue native polyacrylamide gel electrophoresis 
 
For blue native polyacrylamide gel electrophoresis (BN-PAGE; Schagger, 2001), 200 µg 
mitochondrial protein were sedimented by centrifugation (12.000 x g, 10 min, 4°C), 
resuspended in 20 µl low-salt buffer (50 mM NaCl, 5 mM ∋ -aminocaproic acid, 50 mM 
imidazol/HCl, pH 7.0, 1 mM PMSF, 1× proteinase inhibitor cocktail; Roche) containing 
digitonin (Sigma; detergent/protein = 4:1). This detergent has been shown not to disrupt 
complex III/IV supracomplexes (Schagger, 2002). After incubation on ice for 10 min the 
insoluble material was removed by centrifugation (20.000 x g, 20 min). Immediately after the 
addition of 4 µl Coomassie-free loading buffer (10% glycerol, 0.01% Ponceau S), the samples 
were loaded onto polyacrylamide gradient gels as indicated in the text. A high molecular 
weight gel filtration calibration kit (Amersham Pharmacia Biotech) was used to determine the 
apparent molecular weights (thyroglobulin monomer/dimer at 669/1.300 kDa, ferritin at 440 
kDa, aldolase at 158 kDa, bovine albumin at 66 kDa). 
 
2.2.10. In-gel activity assay for complex IV 
 
Solubilized mitochondrial complexes were separated by BN-PAGE under native conditions. 
The activity of complex IV was visualized in the gel as described by Nijtmans et al. (2002). 
Materials and Methods 
 37 
 
2.2.11. Determination of the protein concentration 
 
The protein concentration was determined using the DC protein assay as described by the 
supplier. 
 
2.2.12. Epitope tagging 
 
Fusion of proteins (Cbp3p, Cbp4p, Cor1p) with high affinity tags (e.g. cMyc, HA, Tap) was 
achieved by homologous recombination of the corresponding integration cassettes into a 3´-
region of the chromosomal loci (Knop et al., 1999) of the strains (ZK1-5) as indicated in 
section 2.1.5.2. Integration cassettes for HA-tagging and cMyc-tagging were PCR amplified 
from vector puZV108 (containing three tandem repeates of the HA epitope) and puZV87 
(containing nine tandem repeats of the cMyc epitope, both a kind gift of W. Zachariae, 
Dresden). Integration cassettes for Tap-tagging were PCR amplified from vector pBS1539 
(Rigaut et al., 1999). 
 
2.2.13. Multicopy suppression analysis 
 
The CBP3-cMYC and CBP4-cMYC genes were cloned behind the strong ADH1 and GPD1 
promoters in the multicopy vectors p426ADH and p426GPD, respectively (Humberg et al., 
1995). The plasmids were transformed into the ∆cbp3 and ∆cbp4 strains. The transformants 
were cultured for seven days on YPGly plates.  
 
2.2.14. Thin layer chromatography (TLC) 
 
Isolated mitochondria were purified by gradient centrifugation as described by Meisinger et 
al. (2000) and lipids were extracted as described by Bligh and Dyer (1959). TLC was 
performed on a silica 60 TLC plate (MERCK) using TEA 
(triethylamine)/chloroform/ethanol/water (35:35:40:8, v/v/v/v) as the first mobile phase and 
hexane/ethylacetate (5:1; volume 120 ml) as the second mobile phase. After drying the plate, 
the spots were visualized by incubation with sulphuric acid. 
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2.2.15. Complex III activity measurement 
 
Complex III activity was measured with a spectrophotometer by following the increase in 
reduced cytochrome c absorbance at 550 nm. The reaction buffer consisted of 50 mM 
potassium phosphate (pH 7.4), 0.5 mM EDTA, 0.5 mM KCN, 20 mM succinic acid and 60 
µM cytochrome c. Isolated mitochondria (30 µg of mitochondrial protein) were incubated for 
20 min at 30°C in the reaction buffer lacking cytochrome c. Reaction was started by addition 
of cytochrome c and monitored for 5 min. After 4 minutes the reaction was stopped with the 
complex III inhibitor Antimycin A. The activity is expressed as a first order rate constant (k), 
k = ln (∆E0/∆E1), where ∆E0 is the absorption difference between the start and the end of 
reaction and ∆E1 the absorption difference between the start and the time of 1 minute. 
 
2.2.16. Proteinase K assay 
 
Mitochondria were isolated from yeast by the enzymatic method (Daum et al., 1982) and 
resuspended in 50-100 µl Mannitol-buffer (0.65 M Mannitol, 10 mM Tris/HCl, pH 7.4). Half 
of the isolated mitochondria were used to prepare mitoplasts. Mitoplating was induced by 
diluting mitochondria up to 0.1 M Mannitol and incubation for 30 min. on ice. Prepared 
mitochondria and mitoplasts were treated with increasing concentrations of Proteinase K (0,5-
10 µg of PK per µg of mitochondrial protein) for 30-60 min. on ice in presence or absence of 
1 % Triton X-100. The amount of mitochondria varied between 20-50 µg depending on 
stability and abundance of the analysed protein. After the treatment, Proteinase K was 
inactivated by adding proteinase inhibitors cocktail (PI-Mix) and PMSF (final concentration 1 
mM). Treated mitochondria and mitoplasts were spinned down (12 000 x g, 10 min.) and 
resuspended in 6x Laemmli buffer (final concentration 1x), boiled for 5 min. and loaded on 
the SDS-PAA gel. 
 
2.2.17. Heat shock 
 
Yeast strain (wt) expressing Cbp4p was cultured on YPD and on YPG at 30°C. Upon 
reaching the OD600 = 0,5 (exponential growth phase) the cells were shifted to higher 
temperatures, 37°C and 42°C respectively for 30 min. After the heat shock, 2 ml of culture 
was spinned down, washed with watter and boiled in 50 µl Laemli buffer without the 
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coomassie blue. Protein concentration was meassured as decsribed in section 2.12. Equal 
protein concentration was used for SDS-PAGE. 
 
2.2.18. PET test 
 
PET test is used to complete the complementation analysis of respiratory defective strains 
with mutations in genomic DNA. It verify, if respiratory deficient phenotype is not caused by 
the loss of mitochondrial DNA. PET-tester strains are rho0 (do not contain mitochondrial 
DNA), but contain intact genomic DNA. Haploid strains are crossed with PET tester strains of 
respective MAT locus type (e.g. KL14-4A (=MATa) or IL999-5c (=MATα)) and incubated 
overnight at 30° C on YPD. Respective diploids are then transferred on selective YPG media. 
If the mtDNA of transformants is intact, the diploids are able to grow on YPG media. 
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3. RESULTS 
 
3.1. Protein Homologues of Cbp3p and Cbp4p  
 
The assembly pathways of respiratory chain complexes seem to be evolutionary conserved. 
Both, Cbp3p and Cbp4p are members of larger protein families, which play a role in the 
assembly and/or stability of supramolecular enzymes required for electron transport and ATP 
synthesis. To identify related proteins, the protein sequence of Cbp3p and Cbp4p was used as 
the query for PSI-BLAST analysis against the UniRef90 protein dataset 
(http://www.pir.uniprot.org/database/DBDescription.shtml) and UniProt 
(http://www.pir.uniprot.org). Cbp3p and Cbp4p homologues were identified in various 
organisms beginning from eubacteria (Pasteruella multocida, Clostridium teteni, Bacillus 
cereus), other yeast species (Candida glabrata, Kluyveromyces lactis, Yarrowia lipolytica), to 
plants (Oryza sativa, Ababidobsis thaliana) and higher eukaryots (Drosophila melanogaster, 
Mus musculus, human).  
BLAST-P analysis (Altschul et al., 1997) of Cbp4p revealed a similarity to many proteins that 
act as stress response proteins, e.g. yeast mitochondrial Hsp78 protein (21% identity, 42% 
similarity) or ClpB of the bacterium Brucella melitensis (39% identity, 52% similarity of C-
terminus, 125-162 aa). Hsp78p, a Clp homologue within mitochondria, seems to be involved 
in the turnover of unassembled mitochondrial proteins and can substitute for chaperone 
functions of mt-Hsp70p (Schmitt et al., 1995). ClpB is part of a stress-induced multi-
chaperone system involved in the recovery of the cell from heat-induced damage in 
cooperation with dnaK, dnaJ and grpE. It acts prior to dnaK in the processing of protein 
aggregates (Ekaza et al., 2001). mRNA expression of CBP4 is increased 2-3 fold upon heat 
shock of 15-30 min. (Gasch et al., 2000). Additionally, expression of CBP4 mRNA is 
increased 1,6 fold upon overexpression of Msn4p, a zinc-finger transcription factor that binds 
to the CCCCT sequence, also called “stress response element” (Gasch et al., 2000). Therefore 
I analysed the promoter region of CBP4 for the presence of stress elements. The identification 
of heat-shock elements (AGAAN and CCCCT) in the promoter region of CBP4 suggested 
that expression of Cbp4p may be induced upon the heat-shock. Expression of Cbp4p-cMyc 
was monitored at mild heat shock temperature (37°C) and at high temperature (42°C) as 
described in Materials and Methods (section 2.2.17). Expression of Cbp4p-cMyc was slightly 
increased upon heat shock when cells were growing in YPD medium. Expression of Cbp4p-
cMyc in cells growing on glycerol at all temperatures was increased compared to the cells 
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growing on glucose. Cbp4p-cMyc expression during heat shock in cells growing on glycerol 
was constant (up to 42°C), no further induction of expression was observed (Fig. 6).  
 
 
Figure 6. Expression of Cbp4p upon heat shock. Expression of Cbp4p was monitored upon 30 min. heat 
shock in cells growing on glucose (YPD) or glycerol (YPG). Expression of Cbp4p was slightly increased in the 
cells growing on YPD at 42°C. Cbp4p expression was elevated in all cells growing on YPG; no further increase 
in expression mediated by heat shock was observed. Detection with Pgk1p was used to demonstrate an equal 
protein loading on the SDS gel. 
 
BLAST-P analysis (Altschul et al., 1997) of Cbp3p identified homologues in S. pombe and 
human. Significant similarity of Cbp3p to basic FGF repressed zinc-binding proteins of 
Xenopus laevis, mouse and human (30 - 33 % identity, 48 – 51 % similarity) was revealed. 
The latter three zinc-binding proteins belong to the CBP3 family and have two (mouse) or 
three (human) isoforms (Vetter and Wurst, 2001; Strausberg et al., 2002). The function of the 
proteins and the biological processes, they are involved in, are not known. Cbp3p also shares 
22 % identity and 45 % similarity with mouse heat shock 70 kDa protein 4 (Hsp74p). 
However, neither global mRNA expression micro-arrays analysis, nor monitoring of Cbp3p 
expression (this work) have shown an increase in expression upon heat shock. Accumulation 
of low molecular weight immunoreactive proteins derived from Cbp3p hint at the increased 
turn-over at higher temperatures (data not shown). 
 
3.2. Functional analysis of baker’s yeast Cbp3p and its homologues of S.pombe and 
human 
 
Cbp3p of Saccharomyces cerevisiae (ScCbp3p) is a member of an evolutionary highly 
conserved protein family. While some data are available on ScCbp3p, almost nothing is 
known about its homologues in Schizosaccharomyces pombe (SpCbp3p) and Homo sapiens 
(HsCbp3p). The budding yeast S. cerevisiae and the fission yeast S. pombe are as different 
from each other as either is from mammals, but many S. pombe proteins turned out to be more 
similar to their mammalian homologues than they are to their S. cerevisiae counterparts 
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(Sipiczki, 1995). As Cbp3p is involved in mitochondrial complex III assembly, the 
identification of new mutations with clinical phenotypes can be expected. Therefore, it is 
important to show that these three proteins are orthologues to ensure that knowledge obtained 
from studies on ScCbp3p can be applied for its homologues in other organisms. It was shown 
before that S. cerevisiae and human Cbp3p are imported into mitochondria (Wu and 
Tzagoloff, 1989; V. Petruzzella -personal communication). However, two different cDNA 
clones for Hs-CBP3 were identified. Based on the sequencing data, the two isoforms of 
human Cbp3 (short form and the long form) show differences of the N-termini of the 
translation products, presumably due to alternative splicing of the primary transcript. The long 
form of human Cbp3 protein shows mitochondrial localization. By contrast, the short form of 
h-CBP3 failed to be imported into mitochondria (V. Petruzzella, personal communication). 
Mitochondrial localization of SpCbp3p was assumed on the basis of homology with ScCbp3 
protein, but never experimentally verified. A fusion protein consisting of full length SpCbp3p 
and GFP was constructed and expressed in S. pombe wild type strain (section 2.1.5.3). By 
Western blot analysis I was able to confirm the localization of SpCbp3p in mitochondria (data 
not shown). In the second step the functionality of full length SpCbp3 and HsCbp3p proteins 
in the S. cerevisiae ∆cbp3 strain was monitored. I have to note, that cDNA of the short form 
of h-CBP3 (the one that failed to be imported into human mitochondria) was used to construct 
recombinant plasmid expressing h-CBP3 that we here call as full length HsCbp3p. HsCbp3p 
lack ~ 50 amino acids of the N-terminus compared to ScCbp3p as shown in Fig. 8. The CBP3 
genes from all three organisms were cloned into single copy vector p416ADH and 
transformed into S. cerevisiae ∆cbp3 strain. Complementation analysis was performed at 
three different temperatures (23°, 30°, 37°C) on glycerol, a non-fermentable carbon source, 
where only respiratory competent cells can grow. As expected, ∆cbp3 transformants 
expressing ScCbp3p were growing as wild type cells and HsCbp3p was not able to 
complement the ∆cbp3 mutation in S. cerevisiae. Transformants carrying SpCbp3p showed a 
faint growth at 30°C, whereas no growth at 23° and 37°C was observed (Fig. 7). We 
conclude, that SpCbp3p is partially able to complement the ∆cbp3 mutation in a temperature 
sensitive way.  
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Figure 7. Complementation analysis. Full length CBP3 genes of S. cerevisiae (Sc), S. pombe (Sp) and human 
(Hs) were cloned into the single copy vector p416ADH and transformed to S. cerevisiae cbp3∆ strain. 
Restoration of respiratory growth was tested on YPGlycerol medium at 30°, 23° and 37°C. Two different clones 
from each construct are shown. 
 
As complementation analysis of the human full length protein did not reveal its functional 
homology to ScCbp3p, synthetic chimeric proteins between the ScCbp3p and the HsCbp3p 
were constructed. In addition, two synthetic chimeric proteins between ScCbp3p and 
SpCbp3p were constructed to identify functional domains. Construction of chimeras was 
based on the sequence homology comparison between all three proteins (Fig. 8). As can be 
seen, the central part up to the C-terminus (150-280 aa) is most conserved. To ensure correct 
import of the human protein into yeast mitochondria, the N-terminal end (1-58 aa or 1-144 aa) 
of S. cerevisiae protein was present in the chimeras. Two chimeras, CHP1 and CHP2 were 
constructed carrying the N-terminus of ScCbp3p and differing at the C-terminus. CHP1 
contains the C-trminus of ScCbp3p (292-337 aa), while CHP2 contains C-terminus of SpCbp3 
(section 2.1.10.). The transformants carrying Sc/Sp chimeras (CHP1, CHP2) were respiratory 
competent at 30°C, slightly cold sensitive (23°C) and heat sensitive (no growth at 37°C) (Fig. 
9). Five different Sc/Hs chimeras (Fig. 10 or see section 2.1.10.) were constructed, that were 
analyzed in the same way as the full length protein. Chimeras HC1 and HC2 were not able to 
complement the ∆cbp3 mutation. Three of five chimeras, representing 48.2% of the human 
protein were able to complement the ∆cbp3 mutation. The respective transformants 
expressing chimeric proteins HC3, HC4, HC5 are respiratory competent at 30°C, slightly cold 
sensitive (23°C) and heat sensitive (no growth at 37°C) (Fig. 10).  
The 3 chimeras (HC3, HC4, HC5) represent a yeast model that can be used to test mutations 
of human CBP3 for their pathogenicity. Although ubiquinol-cytochrome c reductase 
deficiencies are rare, pathogenic mutations in the gene encoding mitochondrial cytochrome b 
have been described (Valnot et al., 1999). Mutations in nuclearly-encoded subunits of 
complex III have not been reported so far. However, de Lonlay et al. (2001) reported complex 
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III deficiency in patients with tubulopathy, encephalopathy and liver failure caused by a 
mutation in complex III assembly protein - Bcs1p and Visapää et al. (2002) reported a new 
point mutation in BCS1L in patients with GRACILE syndrom. No cbp3 mutations were 
reported up to now, but the identification of new mutations with clinical phenotypes can be 
expected. 
 
 
Figure 8. Sequence homology comparison. Protein sequences derived from the CBP3 genes of S. cerevisiae 
(Sc), S. pombe (Sp) and human (Hs) were aligned. Identical or highly conserved positions are marked in red, 
amino acids which are identical in two of sequences are marked in blue. 
 
    
Figure 9. Complementation analysis of Sc/Sp chimeric proteins. Two chimeras were constructed by 
overlapping PCR. Numbers on the top of the schemes correspond to amino acid positions at which the sequence 
was switched based on Fig. 8. Chimeras were cloned into single copy vector p414ADH and transformed to S. 
cerevisiae cbp3∆ strain. Restoration of respiratory growth was tested on YPGlycerol medium at 30°, 23° and 
37°C.  
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Figure 10. Complementation analysis of Sc/Hs chimeric proteins. Five different chimeras were constructed 
by overlapping PCR. Numbers on the top of schemes correspond to amino acid positions at which the sequence 
was switched based on Fig. 8. Chimeras were cloned into single copy vector p414ADH and transformed to S. 
cerevisiae cbp3∆ strain. Restoration of respiratory growth was tested on YPGlycerol medium at 30°, 23° and 
37°C. Only transformants expressing HC3, HC4, and HC5 are shown. Transformants expressing HC1 or HC2 
remained respiratory deficient. 
 
PET test analysis (see section 2.2.18.) confirmed that mtDNA was intact in all transformants 
and the respiratory deficient phenotype was caused by the mutation in genomic DNA, which 
can be rescued by the plasmid-born genes. 
 
3.3. Topology of Cbp3p and Cbp4p 
 
By carbonate extraction Cbp3p was shown to be peripherally associated with the membrane 
(Wu and Tzagoloff, 1989), whereas Cbp4p appears to be anchored in the mitochondrial 
membrane, but not exposed on the outer membrane (Crivellone, 1994). The software used to 
predict the transmembrane domains (Persson and Argos, 1994) indicated one transmembrane 
domain in both Cbp3p and Cbp4p. To further characterize the localization (outer membrane, 
intermembrane space, inner membrane) and topology (spatial orientation of N- and C-
terminus) mitochondria and mitoplasts (outer membrane is disrupted) were treated with 
proteinase K (PK) in the absence or presence of detergent. Strain ZK1 expressing Cbp3p-HA 
and Cbp4-cMyc grew on lactate medium to early stationary phase and thereafter mitochondria 
were isolated. Mitochondria and mitoplasts were treated with proteinase K as described in 
Materials and Methods (Fig. 11). Cbp3p is completely protected against PK in mitochondria 
and mitoplasts suggesting its location on the matrix side of inner mitochondrial membrane. 
Cbp4p is protected against PK degradation in mitochondria, but sensitive to increasing 
concentrations of PK in mitoplasts. Detection with antibody against Aconitase (Aco1p), a 
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protein located in the mitochondrial matrix, shows that mitochondria and mitoplasts are not 
disturbed and matrix proteins are protected against the degradation. Sco1p, a mitochondrial 
IM protein that contains one tramsmembrane domain and whose C-terminus is exposed to the 
IMS (Buchwald et al., 1991) is protected against proteinase K in mitochondria, but sensitive 
to degradation with increasing concentration of PK in mitoplasts confirming that mitoplasts 
have been formed. Based on the prediction of one transmembrane domain of Cbp4p, its 
presence in pellet fraction after carbonate extraction and the PK assay shown here, it could be 
concluded that Cbp4p, like Sco1p, is an inner mitochondrial membrane protein with the C-
terminus exposed to intermembrane space.  
 
 
Figure 11. Proteinase K assay. Mitochondria were isolated from strain ZK1 expressing Cbp3p-HA and Cbp4p-
cMyc proteins. Mitochondria (mt) and mitoplasts (mpl) were treated with increasing concentration of PK in the 
absence of detergent. Proteins were analysed by SDS-PAGE and Western blot analysis was performed with 
antibodies directed against the indicated proteins. 
 
It has been reported that glutamate residues in nuclearly encoded mitochondrial inner 
membrane proteins occur ten times more often on the IMS side than on the matrix side, 
suggesting a role of thess aa residues for protein topology (Gavel and von Heijne, 1992). The 
fact that the c-myc epitope contains three glutamate residues may be a factor influencing 
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Cbp4p-cMyc topology. Therefore Cbp4p was tagged with HA epitope, which lacks glutamate 
residues and the PK assay was repeated. Cbp4p-HA is protected in mitochondria, but 
sensitive to increasing PK concentration in mitoplasts (data not shown) confirming the IMS 
orientation of the C-terminus of Cbp4p. 
 
3.4. Cbp3p and Cbp4p interact and are present in common high molecular weight 
complexes. 
 
To test whether Cbp3p and Cbp4p interact in a common structure as mentioned by Shi et al. 
(2001) we constructed strain ZK1-B in which Cbp3p and Cbp4p are replaced by the tagged 
versions Cbp3p-cMyc and Cbp4p-HA (see section 2.1.5.2.). This strain is viable and shows 
no difference in growth on lactate medium compared to the wild type strain (data not shown). 
Functionality of the tagged proteins is also documented by the finding that the combined 
complex II-III activity is comparable to that of the wild type strain (Table 4).  
 
Strain Rate constant (k) 
BY 4741 (wild type) 0,728 
ZK1-B 0,75 
 
Table 4. Complex II-III activity. The activity was measured by monitoring the increase in reduction of 
cytochrome c. It is expressed as a first order rate constant (k), for details see Materials and Methods. cbp3∆ and 
cbp4∆ mutant strains exhibit no detectable activity. 
 
Mitochondrial proteins of strain ZK1-B were separated by BN-PAGE and a subsequent 
second dimension SDS-gel, blotted and analyzed with antibodies against HA, cMyc, Cyt1p 
and Cox3p (Fig. 12). Detection with the Cyt1p antibodies shows that complex III is 
assembled in a dimeric complex of about 700 kDa and in additional complexes of higher 
molecular weight. Anti-Cox3p antibodies detect the complex IV dimer (~ 400 kDa) and in 
addition high molecular weight complexes (≥ 669 kDa), presumably corresponding to 
complex III/IV supracomplexes. These results indicate that formation of complex III and its 
assembly into supracomplexes is not impaired by the tagged versions of Cbp3p and Cbp4p. 
Cbp3p and Cbp4p are both organized in complexes of high molecular weight: the majority of 
the proteins is detected as an continuous streak ranging from > 60 kDa up to > 669 kDa. The 
distribution of Cbp3p and Cbp4p is very similar and may indicate their presence in common 
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complexes. In the case of Cbp4p-HA two additional bands of about 60 and 80 kDa are 
detected (Fig. 12), whose identities are not clear. Possibly they result from protein 
interactions, which persisted the denaturing conditions of the electrophoresis.  
Interestingly a small portion of both Cbp3p and Cbp4p can be detected in the molecular 
weight range of 669 kDa and higher (Fig. 12, lanes A and B) that overlaps with the signals of 
complex III/IV supracomplexes. This offers the possibility that Cbp3p and Cbp4p may not 
only be involved in complex III formation, but also in its assembly to supracomplexes. 
 
Figure 12. Organisation of Cbp3p and Cbp4p. Mitochondrial protein complexes of strain ZK1-B were 
separated by BN-PAGE in a 3-12 % gradient gel and subsequently in the second dimension on a 10 % SDS-gel. 
Antibodies directed against cytochrome c1, Cox3p, HA (Cbp4p) and cMyc (Cbp3p) were used for detection. (A, 
B-supracomplexes of complex III and IV, for details see text) Sizes of marker proteins are indicated. 
 
Physical association of Cbp3p and Cbp4p in vivo was verified by Co-IP. Sepharose-bound 
anti-HA and anti-cMyc antibodies were used to precipitate Cbp4p-HA and Cbp3p-cMyc, 
respectively, from mitochondrial lysate of strain ZK1-B. Both antibodies are highly specific 
for their respective tags and show no cross-reaction with other tags (data not shown). The 
precipitates were separated by SDS-PAGE, blotted and detected with antibodies against cMyc 
(Fig. 13, upper part) or HA (Fig. 13, lower part). In both cases we were able to detect both 
proteins concomitantly in the precipitate. Therefore the Co-IP experiments confirm the 
interaction of Cbp3p and Cbp4p in a stable complex.   
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Figure 13. Co-immunoprecipitation of Cbp3p-cMyc and Cbp4p-HA. Mitochondrial lysate from strain ZK1-
B expressing Cbp3p-cMyc and Cbp4p-HA was incubated with sepharose-bound antibodies against HA or cMyc. 
1/50 of the lysate and the complete precipitates were subjected to SDS-PAGE and detected with cMyc-antibody 
(anti cMyc; upper part) or with HA-antibody (anti HA; lower part). The upper band (*), which is detected with 
the HA-antibody, corresponds to the light chain of antibody which is recognized by the secondary antibodies. 
 
Both, Cbp3p and Cbp4p were identified in different high molecular weight complexes in the 
range between 60 kDa to 700 kDa. Additionally, in the second dimension of BN-PAGE a 
shift of both proteins to higher molecular weight, probably resulting from less sufficient 
denaturing conditions is observed (Fig. 11). We have shown by coimmunoprecipitation that 
Cbp3p and Cbp4p interacts, but detection of signals of both proteins at a different molecular 
weight than that corresponding to Cbp3p/Cbp4p dimer suggest that these proteins may also 
form homodimers. To test this hypothesis a diploid strain (ZK5) expressing Cbp3p-HA and 
Cbp3p-cMyc and a diploid strain (ZK4) expressing Cbp4p-HA and Cbp4p-cMyc were 
constructed. Digitonin-solubilized proteins/complexes of mitochondria isolated from strains 
ZK4 and ZK5 were separated by BN-PAGE in the first dimension and by SDS-PAGE in the 
second dimenion. Cbp4p-HA or -cMyc are detected in the same positions as illustrated in Fig. 
13 by dotted-lines. This suggests that both tagged versions of Cbp4p are assembled into the 
same complexes or interact with the same proteins. Based on BN-PAGE we can not confirm 
or exclude the formation of Cbp4p homodimers. Therefore coimmunoprecipitation (co-IP) 
was performed. The co-IP was performed in the absence and presence of the cross-linker, 
DSP. Cbp4p-HA was precipitated with beads coupled with anti-HA antibody and Cbp4p-
cMyc was precipitated with the beads coupled with anti-cMyc antibody. When precipitated 
with anti-cMyc antibody only very week signal of Cbp4p-HA was detected. Similarly, when 
precipitated with anti-HA antibody, the signal for Cbp4p-cMyc was very weak suggesting no 
formation of Cbp4p homodimers. Interestingly, cytochrome c1 (Cyt1p) was precipitated with 
both Cbp4p-HA or Cbp4p-cMyc in comparable concentration suggesting an interaction of 
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Cbp4p with Cyt1p (Fig. 15). Detection with Cox3p revealed only a very weak signal, except 
upon precipitation with Cbp4p-cMyc in the presence of cross-linker, DSP. 
 
 
Figure 14. Western blot analysis of strain ZK4. Mitochondrial protein complexes of Cbp4p were monitored. 
Solubilized complexes were separated by BN-PAGE in a 5-13 % gradient gel and subsequently in the second 
dimension on a 10 % SDS-gel. Antibodies directed against HA (Cbp4p), cMyc (Cbp4p) and cytochrome c1 were 
used for detection and an overlay of all three proteins is shown. Both Cbp4p are detected in the complexes of the 
same molecular weight. Sizes of marker proteins are indicated with *. 
 
 
Figure 15. Co-immunoprecipitation of Cbp4p-cMyc and Cbp4p-HA. Co-immunoprecipitation was 
performed with lysates from crosslinked (+DSP) or non-crosslinked (-DSP) mitochondria of strain ZK4 
expressing Cbp4p-cMyc and Cbp4p-HA. Solubilized mitochondrial proteins were incubated with sepharose-
bound antibodies against HA or cMyc. 1/50 of the lysate and the complete precipitates were subjected to SDS-
PAGE and detected with antibodies against cMyc-tag, HA-tag, Cyt1p and Cox3p.  
 
The diploid strain ZK5 was used to study formation of Cbp3p homodimers (Fig 16). As 
expected, the organization of Cbp3p is comparable with Fig. 12. We have shown previously, 
that Cbp3p that is HA tagged is not fully functional, but still is able to assemble into some 
complexes as can be seen in Fig. 16. However, Cbp3p-cMyc tagged is functional and 
assembles into higher molecular weight complexes, similar to Cbp4p. The signal of Cbp3p-
cMyc can be followed up to molecular weights corresponding to supracomplexes. Portion of 
Cbp3p (similarly to Cbp4p) overlaps with Cyt1p corresponding to assembled bc1 complex and 
its supracomplexes, highlighted by dotted-lines in Fig. 16. Second dimension analysis after 
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BN-PAGE (Fig. 16) reveals that Cbp3p-HA can be detected at the molecular weight 
corresponding to the monomeric form (42 kDa) as well as in the molecular weight of ~90 
kDa. Cbp3-cMyc tagged is preferentially detected in the molecular weight of ~90 kDa and 
only a very weak signal is detected at the molecular weight corresponding to monomeric form 
(52 kDa). As shown in the overlay, Cbp3p-HA and Cbp3p-cMyc completely overlap in the 
position of ~90 kDa, strongly suggesting, that Cbp3p can make homodimers that persist the 
denaturing condition of SDS-PAGE. We were not able to confirm that hypothesis by 
coimmunoprecipitation, because Cbp3p-HA is not fully functional. Cbp3p-HA can not bind 
Cbp4p and is not able to complement deletion of CBP3 (data not shown). Surprisingly, while 
the interaction of Cbp3p-HA with Cbp4p or itself could not be observed, the interaction of 
Cbp3p-HA or Cbp3p-cMyc with Cyt1p was detected by co-IP (data not shown).  
 
 
Figure 16. Western blot analysis of strain ZK5. Mitochondrial protein complexes of Cbp3p were monitored. 
Solubilized complexes were separated by BN-PAGE in a 5-13 % gradient gel and subsequently in the second 
dimension on a 10 % SDS-gel. Antibodies directed against HA (Cbp3p-HA), cMyc (Cbp3p-cMyc) and 
cytochrome c1 (Cyt1p) were used for detection. Both variants of Cbp3p are detected in different concentration in 
complexes of similar molecular weight (overlay) comigrating with Cyt1p complexes (dotted lines). Sizes of 
approximate protein positions in the SDS PAGE are indicatedby arrows. (*) indicates sizes of protein complexes 
in the first dimension (BN-PAGE). 
 
To test the possibility that Cbp3p forms a homodimer, diploid yeast strain (ZK5-B) 
expressing functional Cbp3p-Tap and Cbp3-cMyc proteins was constructed. Cbp3p-cMyc 
was identified by BN-PAGE in 3 different positions. Similarly to the situation in Fig. 16, the 
first position corresponded to a monomeric form (52 kDa). The two additional signals were 
identified at positions ~70 kDa and ~100 kDa (data not shown). The signal at the position 
~100 kDa could correspond to Cbp3p-cMyc dimer. The signal detected at the position of ~70 
kDa may come from interaction of Cbp3p-cMyc with some other proteins (e. g. with Cbp4, as 
assumed from the approximate molecular weight of Cbp3p/Cbp4p dimer). Detection of 
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Cbp3p-Tap revealed only a very weak signal at position ~100 kDa overlapping with signal of 
Cbp3p-cMyc. To test the possibility of Cbp3p homodimer formation, TAP-purification was 
performed. Cbp3p-cMyc was purified in the first step with IgG beads. After the TEV cleavage 
the supernatant was incubated with calmodulin beads, but Cbp3p-cMyc remained within the 
unbound material and its further purification was not observed (data not shown). Based on 
these results we can not confirm, as well as not exclude the formation of Cbp3p homodimers. 
 
3.4.1. Interacting proteins of Cbp3p  
 
Two putative Cbp3p-interacting proteins, Yar069p and Fyv5p, have been identified in a high-
throughput 2-hybrid analysis (Ito et al., 2001). Both proteins have unknown function and 
intracellular localization. In order to elucidate the function of these proteins, the respective S. 
cerevisiae null mutant ∆YAR069 was constructed. FYV5 null mutant strain was obtained from 
EUROSCARF. The phenotype of both mutants was compared with the phenotype of the 
respiratory defective cbp3∆ strain on media containing glycerol as the only non-fermentable 
carbon source. Both null mutants were respiratory competent but slightly temperature 
sensitive when growing on 23° and 37°C. The respiratory competent phenotypes of the null 
mutant strains of the two candidate proteins, the Fyv5p and Yar069p indicate that these 
proteins are not essential for the respiratory chain assembly. PSORT prediction 
(http://psort.ims.u-tokyo.ac.jp/), Target P V 1.0 (Emanuelsson et al., 2000) and Signal P V 1.1 
(Nielsen et al., 1997) analysis does not predict their mitochondrial localization. Two-hybrid 
analysis often indicate false positive interactions with proteins exhibiting hydrophobic 
transmembrane segments. Both Fyv5p and Yar069p contain putative hydrophobic 
transmembrane segments, Fyv5p has five and Yar069p three. Combined with the fact, that 
deletion of the respective genes does not result in a respiratory deficient phenotype (see 
above), this observation raises the possibility that interaction of these proteins with Cbp3p 
may be artificial. Because of the above mentioned reasons we decided not continue in further 
investigation of these gene products. 
 
3.5. Overexpression of CBP3 and CBP4 in cbp3∆ and/or cbp4∆ strain, respectively 
 
The phenotype of a cbp3∆/cbp4∆ double mutant resembles that of the respective single 
mutants. This, together with the notion of Shi et al. (2001) that Cbp3p might be physically 
associated with Cbp4p, hints at the possibility that the two proteins cooperate in the same step 
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of complex III assembly. To address this question we tested the effect of overexpression of 
CBP3 in the cbp4 null mutant, and vice versa, on respiratory growth. To this end CBP3-cMYC 
and CBP4-cMYC were overexpressed from multi copy plasmids (Fig. 17) in the cbp3∆ and 
cbp4∆ strains. Both tagged genes are able to substitute for the authentic genes. Interestingly, 
upon high level expression in both cases protein variants with reduced electrophoretic 
mobility accumulate. In both cases these proteins might represent precursor forms with 
aminoterminal cleavable mitochondrial targeting sequences. However, we cannot exclude that 
the altered electrophoretic mobility of the proteins results from unknown modifications. The 
cbp3∆ and cbp4∆ transformants were cultured on glycerol as a non-fermentable carbon source 
(Fig. 17). Even after 10 days at 30 °C no growth of the cbp3∆ strain expressing Cbp4p-cMyc 
was observed. Clearly Cbp4p is not able to substitute the function of Cbp3p. In the case of the 
cbp4∆ strain we observe a very faint growth in the untransformed strain as well as in 
transformants bearing CBP3-cMYC on the single copy vector p416ADH. Interestingly upon 
high level expression of Cbp3p from the multicopy plasmids p426ADH or p426GPD growth 
of the transformants is slightly improved compared to the untransformed mutant strain (Fig. 
18). These findings may be explained by a partial compensation of Cbp4p function by a high 
concentration of Cbp3p. 
 
 
Figure 17. High level expression of Cbp3p and Cbp4p. Expression of Cbp3p-cMyc and Cbp4p-cMyc under 
the control of different promoters was monitored. High level expression results in the accumulation of a Cbp4p-
cMyc form with a reduced electrophoretic mobility possibly reflecting a precursor form.  
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Figure 18. Effect of overexpression of Cbp3p-cMyc and Cbp4p-cMyc in the indicated strains on 
respiratory growth. Strains were grown in minimal media at 30 °C. An equal number of cells of OD600 = 0,5 
was diluted as indicated and dropped on the respective plates. Plates were cultured at 30 °C for a maximum of 10 
days. Two different cbp4∆/CBP3 transformants are shown and indicated as (1) and (2). 
 
3.6. Western blot analysis of cbp3 and cbp4 deletion strains 
 
To reveal differences between the deletion strains, the molecular organization of complex III 
was analyzed by BN-PAGE after solubilization with digitonin. Mitochondrial proteins of the 
cbp3∆ and cbp4∆ strains were separated and compared to a wild type and a bcs1∆ mutant 
strain. The latter strain accumulates a dimeric bc1 precomplex of 500 kDa lacking Rip1p and 
Qcr10p (Cruciat et al., 1999). Western blot analysis of the BN-PAGE gel was performed with 
Cyt1p antibodies (Fig. 19). The bcs1∆ mutant strain accumulates the expected bc1 precomplex 
of ~ 500 kDa, whereas in the wild type a complex of > 700 kDa can be detected. This band 
probably corresponds to a supracomplex, consisting of complex III and IV. In the cbp4∆ 
mutant the intensity of the > 700 kDa complex is significantly reduced and accompanied by 
the appearance of a number of low molecular weight bands with a strong accumulation in the 
range of < 150 kDa. In the cbp3∆ mutant only trace amounts of the high molecular complexes 
can be seen, instead some weak bands of lower molecular weight are detected. These results 
are in line with the proposal that Cbp3p and Cbp4p are required for assembly of complex III.  
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Figure 19. BN-PAGE analysis of strains deficient in complex III assembly. Mitochondrial fractions of wild 
type (wt) and the indicated mutant strains were separated by BN-PAGE on a 8-15 % native gradient gel and 
detected with antibodies directed against cytochrome c1. 
 
Complex III assembly of the two mutant strains was further characterized by combining the 
BN-PAGE with a second dimension gel in the presence of SDS (Fig. 20). Complex III 
subcomplexes were characterized with antibodies against Cyt1p, whereas an antibody against 
Cox3p was used to identify supracomplexes of complex III and IV. Complex V assembly was 
tested with the Atp2p antibody.  
No differences between the various strains were observed upon detection with the Atp2p 
antibody, indicating that complex V assembly is not disturbed in the cbp3∆ and cbp4∆ 
mutants. Detection with Cyt1p antibodies confirms the results of the BN-PAGE: in wild type 
cells Cyt1p is almost exclusively organized in high molecular weight complexes (> 650 kDa) 
(designated “S”), whereas in the cbp3∆ strain Cyt1p is detected in various smaller complexes 
ranging from 100 to ~ 500 kDa. The cbp4∆ strain reveals a similar pattern of complexes in the 
lower molecular weight range, but in addition a high molecular weight complex of > 700 kDa 
can be detected.  
Western blot analysis with the Cox3p antibody identifies a complex of about 400 kDa in all 
strains (Fig. 20), which represents the complex IV dimer (IVDIM). Obviously, COX-assembly 
is not affected in any of the mutant strains. In wild type cells one or even more additional 
complexes of higher molecular weight can be detected, which are probably supracomplexes of 
complex III and IV as reported by Cruciat et al. (2000). These supracomplexes are completely 
absent in the cbp3∆ mutant, whereas in the cbp4∆ mutant a faint band corresponding to a 
complex of about 700 kDa (designated “Y”) is seen. This complex could correspond to a 
complex III/IV supracomplex. The identified supracomplexes were tested for COX-activity 
Results 
 56 
by an in-gel activity test (Fig. 21). Whereas the wild type complexes exhibit a high activity, 
the > 700 kDa complex detected in the cbp4∆ strain yields only a very weak signal. 
The complex of about 500 kDa, which can be seen in the cbp3∆ mutant (designated “X”) 
could reflect a dimeric bc1 precomplex that is probably non-functional as can be deduced 
from the respiratory defective phenotype of the mutant. 
 
 
Figure 20. Western blot analysis of respiratory chain complexes. Mitochondrial fractions of wild type (wt) 
and the indicated mutant strains were separated by BN-PAGE in a 8-15 % gradient gel and in the second 
dimension on a 10 % SDS-gel. Antibodies directed against cytochrome c1, Cox3p and Atp2p were used for 
subsequent detection. Overlays of the resulting films are shown. (VDIM- dimer of complex V, VMON- monomer of 
complex V, IVDIM- dimer of complex IV, IIIDIM- dimer of complex III, S- supracomplex of IIIDIM in combination 
with IVMON or IVDIM, X-complex III precomplex, Y- supracomplex of complex III and IV, details see text) 
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Together these results show that deletion of CBP3 or CBP4 result in a disturbance of complex 
III assembly which is associated – especially in the cbp3∆ mutant - with the accumulation of 
similar low molecular weight complexes. At the same time BN-PAGE revealed a clear 
difference between cbp3∆ and cbp4∆ mutant strains in the form of a putative COX-positive 
supracomplex which is exclusively detected in the cbp4∆ mutant. 
 
 
Figure 21. In-gel activity of cytochrome c oxidase. Mitochondria from the indicated strains were solubilized 
with digitonin on ice and loaded onto a 5–13 % native gradient gel. In-gel activity assay for COX was performed 
as described in Materials and Methods. Protein bands exhibiting COX activity are marked by stars. Other visible 
bands result from Coomassie blue staining. 
 
3.7. Analysis of complex III assembly 
 
The process of bc1 complex assembly is not fully understood. As outlined in the introduction, 
probably three sub-complexes are formed before the enzyme is fully assembled.  
cbp3 and cbp4 null mutant strains accumulate different intermediate-sized bc1-complexes, as 
outlined above. Because of the lack of antibodies recognising subunits of complex III we 
were not able to determine the protein composition of these complexes. Therefore at least one 
subunit from each of the proposed bc1-subcomplexes was tagged with a high-affinity epitope 
and expressed from its natural chromosomal position in wild type, cbp4- and cbp3- null 
mutant strains (see section 2.1.5.2). Although it is clear that Cbp3p and Cbp4p are assembly 
factors of the bc1 complex, it remains to be elucidated in which step of the bc1 complex 
assembly they act. Two methods have been chosen to study the assembly of the bc1 complex, 
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the Blue Native PAGE (BN-PAGE) and Tandem affinity Purification methods (TAP). 
Mitochondria isolated from respective strains were solubilized with digitonin, complexes 
analysed by BN-PAGE and protein interaction were studied with TAP method. 
 
3.7.1. BN-PAGE analysis 
 
According to the model of bc1 comlex assembly (see introduction) three subcomplexes are 
assembled into a functional enzyme. I have already analysed the relationship of Cbp3p and 
Cbp4p with one of these subcomplexes, the cytc1-subcomplex. BN-PAGE analysis of strain 
ZK1B (Fig. 12) revealed that the signals of Cbp3p and Cbp4p are overlapping with the signal 
for Cyt1p; co-IP analysis showed that both assembly factors interact with Cyt1p (Fig. 15). 
The strains expressing Cor1p-Tap were prepared to analyse the relationship of the two 
assembly factors to Cor1p, a subunit of the core subcomplex. Proteins from digitonin-
solubilized mitochondria of wt-, ZK3, cbp3- and cbp4- null mutant strains expressing Cor1p-
Tap were separated under native conditions (BN-PAGE), followed by separation under 
denaturing conditions (SDS-PAGE) in the second dimension. In wild type strain, the Cor1p-
Tap was exclusively located in the 3 different complexes in the range of ~700 - 1MDa 
corresponding to different supracomplexes (Fig. 22A). This means that the TAP-tag Cor1p is 
functional and does not interfere with complex III assembly. In strain ZK3 we see the same 
organization of Cor1p except for an additional signal in the lower molecular weight range that 
could represent assembly intermediate(s). As mentioned earlier, in the ∆cbp4 strain we were 
able to detect a high molecular weight complex with anti-Cyt1p antibody, corresponding to 
the bc1-supracomplex. A complex of the same molecular weight was detected also with 
Cor1p-Tap antibody (Fig. 22B). Surprising results were obtained with the ∆cbp3 strain 
expressing Tap-tagged Cor1p. I was able to detect Cor1p-Tap in the SDS-PAGE, but never in 
the BN-PAGE suggesting that Cor1p is present in the mitochondria, but not assembled into a 
complex. Interestingly, detection with the Cyt1p antibody in all strains except for the ∆cbp3-
Cor1p-Tap strain reveals 3 main spots in the lower molecular weight range that probably 
represent subcomplexes of bc1 complex. Cyt1p was also detected in a high molecular weight 
region where it colocalizes with the Cor1p-Tap respresenting assembled (supra)-complexes. 
In the ∆cbp4 strain the signals in the lower molecular weight were increased, probably due to 
accumulation of pre-assembled complexes or due to degradation of non-assembled enzyme. 
As shown earlier (Fig. 20) in the ∆cbp3 strain, the bc1 complex is not assembled and different 
pre-assembled or degraded complexes in the low molecular weight range are accumulating. 
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(Fig. 22B). These data also suggest that the effect of CBP3 deletion on the bc1 complex 
assembly is more severe than the deletion of CBP4.  
 
A B  
Figure 22. Assembly of Cor1p and Cyt1p into bc1-complex. Assembly of Cor1p-subcomplexes and Cyt1p-
subcomplexes were monitored in the wild type (wt), ZK3, ∆cbp3 and ∆cbp4 strains. Solubilized mitochondrial 
complexes were separated by BN-PAGE in a 8-15 % gradient gel and subsequently in the second dimension on a 
10 % SDS-gel. Antibodies directed against TAP-tag (A, Cor1p-Tap) and cytochrome c1 (B, Cyt1p) were used for 
detection. The results suggest that deletion of CBP3, but not CBP4 has a negative effect on Cor1p stability 
and/or assembly. 
 
Organization of Cbp3p and Cbp4p compared to Cor1p and Cyt1p is shown in Fig. 23. Cor1p 
is assembled into 3 distinct supracomplexes and into additional low molecular weight 
complexes. However, distribution of Cbp3p and Cbp4p is different compared to Cor1p, but 
presence of both assembly factors in the complexes containing Cor1p is detected. 
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Figure 23. Organization of Cbp3p-HA and Cbp4p-cMyc compared to Cor1p and Cyt1p. Solubilized 
mitochondrial complexes of strain ZK3 were separated by BN-PAGE in a 8-15 % gradient gel and subsequently 
in the second dimension on a 10 % SDS-gel. Antibodies directed against TAP-tag (Cor1p-Tap), cytochrome c1 
(Cyt1p), cMyc (Cbp4p-cMyc) and HA (Cbp3-HA) were used for detection. Cbp3p-HA and Cbp4p-cMyc are 
present in complexes of similar molecular weight, some overlapping with positions of Cor1p and Cyt1p. Signals 
of both assembly factors can be followed to molecular weight corresponding to supracomplexes (shown by 
dotted-line). 
 
Qcr7p and Qcr8p are subunits of the third proposed subcomplex that we call cytb-
subcomplex. These two proteins were TAP-tagged (Ghaemmaghami et al., 2003) in the wild 
type strain (see section 2.1.5.2). Unfortunately, ∆cbp3 and ∆cbp4 strains expressing HA- or 
cMyc-tagged version of Qcr7p or Qcr8p could not be obtained. Wild type strains expressing 
TAP-tagged versions of Qcr7p and Qcr8p are viable and grow on non-fermentable carbon 
source. BN-PAGE analysis of strains expressing Qcr7p-Tap or Qcr8p-Tap reveals that the 
Tap-tag does not affect the assembly of cytb-subcomplex. Detection of Rip1p and Cyt1p 
manifests that the bc1 complex is assembled. Formation of supracomplexes was checked with 
detection of Cox3p. Cox3p is assembled in complex IV dimer and in the supracomplexes 
consisting of complex III/IV (Fig. 24 and 25). This suggests that formation of supracomplexes 
is not disturbed. Organization of Cbp3p-cMyc and Cbp4p-HA was not influenced by TAP-
tagged Qcr7p and Qcr8p (Fig. 26). Both assembly factors were detected in the same positions 
as shown earlier (Fig. 12 and Fig. 23). Both assembly factors are present in complexes of 
different molecular weight, including positions corresponding to high molecular weight 
complexes. 
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Figure 24. Assembly of Qcr7p and Cyt1p into complex III. Assembly of Qcr7p and Cyt1p into complexes 
was monitored in the wild type strain expressing Tap-tagged Qcr7p. Solubilized mitochondrial complexes were 
separated by BN-PAGE in a 8-15 % gradient gel and subsequently in the second dimension on a 10 % SDS-gel. 
Antibodies directed against TAP-tag (Qcr7p-Tap) and cytochrome c1 (Cyt1p), Rieske Fe-S (Rip1p) and Cox3p 
were used for detection. 
 
 
 
Figure 25. Assembly of Qcr8p and Cyt1p into complex III. Assembly of Qcr8p and Cyt1p into complexes 
was monitored in the wild type strain expressing Tap-tagged Qcr8p. Solubilized mitochondrial complexes were 
separated by BN-PAGE on a 8-15 % gradient gel and subsequently in the second dimension on a 10 % SDS-gel. 
Antibodies directed against TAP-tag (Qcr8p-Tap) and cytochrome c1 (Cyt1p), Rieske Fe-S (Rip1p) and Cox3p 
were used for detection. 
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Figure 26. Neither Qcr7p-Tap nor Qcr8p-Tap affects the organization of Cbp3p or Cbp4p. Solubilized 
mitochondrial complexes of three different strains (A, B, C) were separated by BN-PAGE on a 8-15 % gradient 
gel and subsequently in the second dimension on a 10 % SDS-gel. Antibodies directed against TAP-tag (Qcr8p-
Tap or Qcr7p-Tap), cMyc (Cbp3p-cMyc) and HA (Cbp4p-HA) were used for detection. (all strains are wild type 
strains; strains A and B express Qcr7p-Tap and Qcr8p-Tap, respectively, from gDNA and Cbp3p-cMyc from a 
plasmid-born gene; strain C expresses both Qcr8p-Tap and Cbp4p-HA from the gDNA, g = genomic).  
 
3.7.2. TAP purification  
 
By using the TAP purification method, interactions of Cbp3p and Cbp4p proteins with the 
subunits of bc1 complex were studied. Interaction of both, Cbp3p and Cbp4p with Cyt1p was 
observed by co-IP (Fig. 15). The strains ZK3 (Cor1-Tap, Cbp3-HA, Cbp4-cMyc), ∆cbp4-
Cor1-Tap and ∆cbp3-Cor1-Tap were used to study the interactions of Cor1p with other 
subunits of the bc1 complex and to analyse the relationship of the two assembly factors to 
Cor1p.  
Cytochrome c1 was precipitated in the final eluate via Cor1p-Tap in the strains ZK3 and 
∆cbp4-Cor1-Tap, but increased degradation of Cyt1p was observed in the latter strain. In the 
∆cbp3-Cor1-Tap strain a strong degradation of Cor1p-Tap and no interaction with 
cytochrome c1 was observed. The interaction between Cor1p and Cbp4p-cMyc could not be 
detected. Cbp3p-HA was not detected in the final eluate, but in the eluate from calmodulin 
beads (CaB). In the further purification with Immunoglobuline G (IgG) beads the signal of 
Cbp3p-HA was no longer detectable (data not shown).  
In the next step, the interactions of Qcr7p-Tap and Qcr8p-Tap with Cbp3p-cMyc and Cbp4p-
HA assembly factors was analyzed. I was able to precipitate cytochrome c1 with both Qcr7p-
Tap and Qcr8p-Tap. Interaction of Cbp3p-cMyc with Qcr7p-Tap or Qcr8p-Tap was not 
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detected. Cbp4p-HA was purified with Qcr8p-Tap to IgG beads, but the signal in the further 
purification was very weak and not detectable in the final eluate. The interactions of bc1 
complex subunits and of both assembly factors are summarized in the Table 5. 
 
Purified proteins: TAP purification 
with TAP-tagged: Cyt1p Cbp3p Cbp4p 
Cor1p-Tap in wt ! ! " 
Cor1p-Tap in ∆cbp3 "   
Cor1p-Tap in ∆cbp4 !   
Qcr7p-Tap in wt ! " " 
Qcr8p-Tap in wt ! " ! 
Table 5. Summary of TAP-purification. Subunits of bc1 complex, namely Cor1p, Qcr7p and Qcr8p were TAP-
tagged and used for purification. Interactions of these subunits with Cyt1p and with assembly factors Cbp3p and 
Cbp4p were monitored. Purification of the protein with the respective TAP-tagged subunit is shown by !. No 
detected interaction is indicated by ". 
 
3.8. Cbp3p and Cbp4p are presumably not involved in mitochondrial lipid 
metabolism 
 
Phospholipids are essential for the activity of several membrane proteins (Dowhan, 1997), 
including complex III (Schägger et al., 1990). A characteristic lipid of the inner mitochondrial 
membrane is cardiolipin, which has been shown essential for complex III activity (Gomez and 
Robinson, 1999). Cardiolipin is associated with Cobp and is required for the formation of 
complexes III/IV supracomplexes (Zhang et al., 2002). A role of other phospholipids such as 
phosphatidylethanolamin (PE) or phosphatidylinositol (PI) in stabilization of bc1 complex has 
been proposed (Lange et al., 2001). As supracomplex formation seems to be affected in 
cbp3∆ and cbp4∆ mutant strains (see Fig. 20 and 21), we analysed the lipid composition of 
the deletion strains and compared it with that of the respective transformants bearing the wild 
type genes on a plasmid, and of the wild type strain. To exclude secondary effects due to 
respiratory deficiency, we also included the respiratory deficient cyt1∆ strain in the analysis. 
Mitochondrial preparations of all strains were used for lipid extraction and the lipids were 
separated by TLC as described in Material and Methods. As shown in Fig. 27, the 
concentrations of CL and of the other lipids do not differ significantly between the strains.  
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To exclude the possibility that Cbp3p or Cbp4p act in cardiolipin biosynthesis we analysed 
complex III and IV assembly of crd1∆ and taz1∆ mutants by BN-PAGE. CRD1 is a structural 
gene encoding cardiolipin synthase. The crd1∆ strain possesses no detectable CL and exhibits 
a growth defect in galactose and in non-fermentable carbon sources (Zhong et al., 2004). The 
TAZ1 gene, which encodes a putative acyltransferase, is required for the normal phospholipid 
content of mitochondrial membranes. Similar to human tafazzin, which is implicated in Barth 
syndrome (Gu et al., 2004), Taz1p may remodel the acyl groups of cardiolipin in the inner 
mitochondrial membrane. If Cbp3p or Cbp4p would be involved in CL biosynthesis or its 
remodeling, cbp3∆ and cbp4∆ strains should exhibit a phenotype similar to that of crd1∆ and 
taz1∆ mutants. BN-PAGE analysis revealed that both the crd1∆ and taz1∆ mutant strain 
exhibit a fully assembled complex III (detected with Cyt1p antibody) (Fig. 28). Detection 
with Cox3p antibody confirmed that CL is required for supracomplex formation as complex 
IV is present only in the dimeric form (∼  400 kDa) in crd1∆ (no CL is present) compared to 
taz1∆ mutant (CL is present), where complex III/IV supracomplexes are formed (Fig. 28). 
The pronounced impairment of complex III formation and the presence of CL in cbp3∆ strain, 
however, argues against an involvement of Cbp3p in CL synthesis or remodeling. In the case 
of cbp4∆ mutant strain, where we can observe supracomplex formation as in the taz1∆ 
mutant, an involvement of Cbp4p in CL remodeling cannot be completely excluded. 
However, the clear effect of CBP4 deletion on complex III formation as well as the 
association of Cbp4p with Cbp3p favours the idea that it acts as a specific complex III 
assembly factor.  
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Figure 27. Lipid composition. Lipids were extracted from mitochondria of the indicated strains and analysed by 
Thin Layer Chromatography (TLC) as described in Material and Methods. (PC-phosphatidylcholin, PS-
phosphatidylserin, PI-phosphatidylinositol, PE-phosphatidylethanolamin, CL-cardiolipin, CHOL-cholesterol, 
DAG-diacylglycerol, TAG-triacylglycerol). 
 
 
 
Figure 28. Western blot analysis of respiratory chain complexes in crd1∆ and taz1∆ strains. Mitochondrial 
fractions of the indicated mutant strains were separated by BN-PAGE in a 8-15 % gradient gel and in the second 
dimension on a 10 % SDS-gel. Antibodies directed against cytochrome c1 and Cox3p were used for detection.  
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4. DISCUSSION 
 
Cbp3p of Saccharomyces cerevisiae (ScCbp3p) is a member of an evolutionary conserved 
protein family with homologues identified in many organisms. In this study we have 
confirmed that the Cbp3p proteins of S. cerevisiae, S. pombe and human are functional 
homologues. We demonstrated that full length SpCbp3 and chimeras of human and S. 
cerevisiae proteins are able to complement the deletion of the CBP3 gene in baker´s yeast. 
The full length HsCbp3p was not complementing the CBP3 deletion in spite of the high 
sequence homology. However, it was expected because the human protein lacking more than 
50 amino acid residues in the N-terminal part as can be seen from sequence comparison (Fig. 
8) was used. This short form of h-CBP3 failed to be imported even to human mitochondria 
(V. Petruzzella, personal communication), suggesting that its import to the yeast mitochondria 
is as well disturbed. Therefore chimeric human/S. cerevisiae proteins were constructed that 
contain the N-terminal part derived from yeast, the central most conserved region from the 
human protein and C-terminal part (that is lacking in human protein) also derived from yeast. 
Surprisingly, chimeras HC1 and HC2 containing a large central part of human gene were not 
complementing the CBP3 deletion in S. cerevisiae suggesting that the most conserved regions 
are not sufficient for the protein function. Therefore three other chimeras were constructed 
where the central conserved part was divided into two halves. All three chimeras (HC3, HC4, 
HC5) were complementing the CBP3 deletion in S. cerevisiae. Why can the central region 
when in total not complement for ScCbp3p function, but can when divided into two parts? 
Thorough inspection of protein sequence comparison revealed significant differences between 
yeast (both S. cerevisiae and S. pombe) and human proteins in the regions between amino acid 
residues 170-194 and 207-224. While S. cerevisiae and S. pombe share significant homology, 
human protein differs almost in all amino acids within these regions. This fact may explain 
why even a full length SpCbp3p can partially complement cbp3 deletion in S. cerevisiae, but 
not human full length Cbp3p and chimeras HC1 and HC2, which lack the mentioned regions. 
The importance of residues in these regions is also supported by study of Shi et al. (2001) 
where the authors showed that the mutation of Gly223 influenced Cbp3p functional activity 
and affected assembly of the 14 kDa subunit (Qcr7p) of bc1 complex. Additionally, they 
showed that mutations in the region between Leu167 to Pro175 altered the association of 
Cbp3p with the mitochondrial membrane resulting in enhanced protein turnover. All the 
mentioned residues are not present in human homologue and therefore only chimeras 
containing at least one half of central region from S. cerevisiae and the second from human 
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(HC3, HC4, HC5) can complement for the ScCbp3p function, albeit only in a temperature 
sensitive way. Shi et al. (2001) showed that regions Lys124-Ala140, Leu167-Pro175 and 
Gly223-Asp229 are important for Cbp3p function or stability. Our studies confirm that these 
regions belonging to the most conserved part seem to be important for the function of S. 
pombe and human genes and extend functionally important regions of ScCbp3p to residues 
170-194 and 207-224.  
 
4.1. Organization of Cbp3p and Cbp4p 
 
Both Cbp3p and Cbp4p are mitochondrial proteins associated with or anchored in the 
membrane, respectively. In this study we have treated mitochondria and mitoplasts with 
proteinase K in order to determine the location and topology of both proteins. PK analysis 
shows that Cbp3p C-terminus is protected against degradation in mitochondria. Slight 
decrease of the signal in mitoplasts after addition of PK is probably due to disrupted 
mitoplasts when a small portion of Cbp3p became accessible to proteinase K. Importantly, the 
signal intensity of Cbp3p remains stable with further increase of PK concentration suggesting 
the C-terminus being located on the matrix side of inner mitochondrial membrane. Based on 
a) the fact that upon treatment with PK we see no shift of Cbp3p during separation on SDS-
PAGE, b) the results of alkaline extraction suggesting its membrane association (Shi et al. 
2001) and c) the principle of protein import to mitochondria we assume that also the N-
terminus of Cbp3p faces the matrix side of mitochondria.  
A different behavior is detected for Cbp4p. Cbp4p seems to be extremely sensitive to 
proteinase K and we can see its partial degradation already in PK-treated mitochondria, 
suggesting disturbances of the outer mitochondrial membrane (Cbp3p is also degraded in 
mitochondria treated with the highest PK concentration). Additionally, other experiment in 
which mitochondria were treated with high concentration of PK (5 µg/µg) for one hour and 
sample was taken every 10 min. (data not shown) confirmed that Cbp4p is protected in 
mitochondria, as shown by Crivellone (1994). Alkaline extraction shows that Cbp4p seems to 
be integral membrane protein (Crivellone, 1994) with the C-terminus facing the inner 
membrane space as has been shown in this study by PK assay. 
Even though these data show different topologies of Cbp3 and Cbp4p we have shown by Co-
IP (Fig. 13) that Cbp3p and Cbp4p interact. Presently we don´t know whether this interaction 
is direct or mediated by so far unknown components, e.g. subunits of precomplexes, which 
could also explain the presence of both proteins in common high molecular weight 
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complexes. This possibility is supported by a similar distribution of both Cbp3p and Cbp4p 
with Cyt1p (Fig. 12) and the fact that Cyt1p was precipitated with both Cbp3p and Cbp4p 
(Fig. 13). Alternatively, these high molecular weight complexes may correspond to 
heteromeric structures as reported for prohibitins (Back et al., 2002; Nijtmans et al., 2002a). 
To test this hypothesis the homomer formation of Cbp3p and Cbp4p, respectively was 
analysed by BN-PAGE and Co-IP in the diploid strains ZK4 and ZK5. Cbp4p-HA and -cMyc 
were concomitantly expressed in ZK4 strain and detected at the same positions in BN-PAGE. 
This observation suggests that both tagged versions of Cbp4p are functional and either 
assembled into the same complexes or interact with the same proteins. To confirm or exclude 
the formation of Cbp4p homodimers a co-IP was performed. The results of co-IP give no 
indication for Cbp4p to form homodimers, because Cbp4p-HA could not be purified via 
antibodies directed to Cbp4p-cMyc and vice versa. Importantly, co-IP analysis showed strong 
interaction of Cbp4p with Cyt1p that was already indicated by BN-PAGE where Cbp4p and 
Cyt1p had similar distribution. This fact can also explain the presence of a very weak signal 
of Cbp4p-HA precipitated with Cbp4p-cMyc antibodies and vice versa. All latter data support 
the interpretation that Cbp4p does not form homodimers. Surprisingly, Cox3p a subunit of 
complex IV that assembles with bc1 complex to a supracomplex was precipitated with Cbp4p 
if cross-linker was present. This suggests that Cbp4p could be cross-linked to the 
supracomplex consisting of complex III and complex IV suggesting a role of Cbp4p not only 
in complex III assembly but also in formation of supracomplexes. The exact role of Cbp4p in 
supracomplex formation is not clear because tiny amounts of supracomplex in ∆cbp4 strain is 
observed (Fig. 20), however complex IV is preferentially detected in the dimeric form. 
Therefore the presence or the interaction of both Cbp3p and Cbp4p may be essential for 
supracomplex formation. The observation of a high molecular weight structure (“A” in Fig. 
12 and Fig. 16), which yields signals for Cbp3p may hint at the possibility that the presence of 
these two proteins may be important for supracomplex formation. 
BN-PAGE analysis of ZK5 strain suggests that Cbp3p may form homodimers (Fig. 16), but 
this possibility could not be tested, because of the disturbed functionality of HA tagged 
Cbp3p. The co-IP analysis of mitochondrial lysate of ZK5 strain did not reveal any interaction 
between Cbp3p molecules. Therefore, another approach, the TAP method was used to prove 
formation of Cbp3p homodimers. Cbp3p was Tap-tagged and diploid strain (ZK5-B) 
expressing Cbp3p-Tap and Cbp3-cMyc was constracted. BN-PAGE analysis of mitochondrial 
complexes of strain ZK5-B again confirmed the presence of Cbp3p in high molecular weight 
complexes in the first dimension and a shift in molecular weight of Cbp3p in the second 
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dimension. Signals of both Tap- and cMyc-tagged Cbp3p overlapped at the position of ~100 
kDa, which could correspond to molecular weight of a Cbp3-cMyc/Cbp3-Tap dimer. 
However, it is difficult to confirm the formation of Cbp3p homodimers, even though Cbp3p-
cMyc was purified with Cbp3p-Tap in the first step of TAP- purification. If Cbp3p would 
form homodimers, then three different forms of dimers are expected in BN-PAGE, as 
summarized in Table 6. The differences in molecular weight between the respective putative 
dimers are about 8 and 16 kDa. These differences may be too small, to be resolved in 10% 
SDS-PAGE used in the second dimension. Additionally, only a very weak signal of Tap-
tagged Cbp3p was obtained, hinting at the possibility, that the epitope for anti-Tap antibody is 
partially hidden. Therefore, we can not conclude that Cbp3p is able to form dimers, but we 
can not exclude this possibility. A convenient method to prove protein dimerization would be 
FPLC (fast protein liquid chromatography) that was also used to study the role of 
oligomerization of subunit III of complex IV (Finel and Wikstrom, 1986). An alternative 
approach to study Cbp3p dimerization would be to combine BN-PAGE for separation of 
Cbp3p complexes and mass spectrometry (e. g. MALDI-TOFF) for identification of proteins 
present in the analysed complex. Such an approach has been used to study prohibitin 
oligomerization (Back et al., 2002). 
 
Dimer Molecular weight 
Cbp3p-Tap/ Cbp3p-Tap ~116 kDa 
Cbp3p-Tap/ Cbp3p-cMyc ~108 kDa 
Cbp3p-cMyc/ Cbp3p-cMyc ~100 kDa 
Table 6 Putative dimers formation. Diploid strain ZK5-B expressing two differently tagged Cbp3 proteins, 
Cbp3p-Tap and Cbp3p-cMyc was used to study Cbp3p dimerization. In case of dimerization three possible 
dimers are expected to be formed with respective molecular weights. 
 
Surprisingly, the interaction of Cbp3p-HA or -cMyc tagged with Cyt1p was detected (data not 
shown). Is the interaction observed for Cbp3p and Cbp4p direct or mediated via Cyt1p if both 
proteins interact with Cyt1p? If the interaction of Cbp3p and Cbp4p would be mediated via 
Cyt1p then Cbp4p would be precipitated also with Cbp3p-HA that is still able to bind to 
Cyt1p. Probably the HA-tag influences the interaction of Cbp3p with Cbp4p and this causes 
its partial non-functionality. All these data suggest that interaction of Cbp3p with Cbp4p is 
rather direct or mediated through other subunits of bc1 complex than Cyt1p. 
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Interestingly, two protein variants of Cbp3p appear in the Western blot analysis of second 
dimension of BN-PAGE. We have discussed earlier that one of the two variants of Cbp3p 
with different electrophoretic mobility may represent a precursor form. However, this 
interpretation does not seem to be probable, because both forms are assembled into complexes 
of high molecular weight. The second form could raise from translation initiated on an 
additional AUG codon. Therefore, I have analysed the sequence of ScCBP3 and additional 
ATG codons were found downstream of the first ATG codon. However, initiation of 
translation on these additional codons seems to be not probable, because of the presence of 
not only one, but the two ATG codons at the 5`end of the CBP3 coding region. Interestigly, 
two different cDNA clones for Hs-CBP3 were identified. Based on the sequencing data, the 
two isoforms of human Cbp3 (short form and the long form) show differences of the N-
termini of the translation products, presumably due to alternative splicing of the primary 
transcript. The long form of human Cbp3 protein shows mitochondrial localization. By 
contrast, the short form of h-CBP3 failed to be imported into mitochondria (V. Petruzzella, 
personal communication). It is not probable that yeast Cbp3p exists in the two different 
splicing forms, because yeast CBP3 does not contain any introns and no reports of alternative 
splicing in yeast was published up to now. The evaluation of this possibility is a challenge for 
further investigation. 
 
4.2. Characterization of deletion strains and effect of Cbp3p and Cbp4p overexpression 
 
The respiratory deficient cbp3∆ and cbp4∆ strains lack ubiquinol-cytochrome c reductase 
activity and show reduced steady-state levels of some complex III subunits including Cobp 
and Rip1p. Based on these findings it was proposed that Cbp3p and Cbp4p act as chaperones 
in the formation of complex III (Wu and Tzagoloff, 1989; Crivellone, 1994). 
In this study we provide experimental evidence that Cbp3p and Cbp4p are indeed complex III 
assembly factors. We used BN-PAGE to characterise the mitochondrial respiratory complexes 
in both mutants. Complex III assembly was followed with antibodies against Cyt1p, the 
subunit which seems to be least influenced by the absence of other subunits of the complex 
(Zara et al., 2004). Unlike in wild type cells, in cbp3∆ and cbp4∆ mutant strains Cyt1p is not 
detected in distinct spots, but rather in the form of long drawn-out bands covering a wide 
molecular weight range up to about 700 kDa (Fig. 20). Although this size corresponds to the 
monomeric and dimeric form of the bc1 complex, complex II/III activity was undetectable. 
Therefore these complexes must represent either unproperly assembled complex III or 
aggregates of accumulated subunits or pre-complexes. The failure to detect Cyt1p in distinct 
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spots may hint at disturbances in the process of complex III assembly leading to the 
accumulation of various intermediate-sized complexes which are prone for degradation. The 
similar distribution of Cyt1p in both mutants strengthens the idea that the two proteins are 
engaged in the same step(s) in the formation of complex III. However, there is one striking 
difference between the two mutants: in the cbp4∆ mutant a high molecular weight complex 
(“Y” in Fig. 20) can be detected, which is absent in the cbp3∆ mutant. Detection of a complex 
with identical size by Cox3p antibody strongly suggests that it corresponds to a complex 
III/IV supracomplex. This complex possesses no detectable ubiquinol-cytochrome c reductase 
activity (Table 4), but a substantial COX-activity in the in-gel assay (Fig. 21). According to 
these data Cbp3p is required for supracomplex formation, whereas the role of Cbp4p in the 
association of complex III and IV is less clear. In line with this conclusion Cbp3p can be 
detected in high molecular weight complexes (“A” and “B” in Fig. 12), which are likely to 
represent complex III/IV supracomplexes. However, Cbp4p is also detectable in “B”, albeit at 
a low concentration, suggesting that it is also associated with some forms of supracomplexes.  
What is the molecular basis of the observed complex III assembly deficiency in the cbp3∆ 
and cbp4∆ mutants? Inspection of the data provided by Wu and Tzagoloff (1989) show that 
the cbp3∆ mutant has reduced steady state concentrations of Qcr7p (“core 4”), Qcr8p (“core 
5”), Rip1p and Cobp, whereby the levels of Qcr7p and Cobp are more severly reduced 
compared to Qcr8p. Analysis of complex III subunits in the cbp4∆ mutant by Crivellone 
(1994) revealed a similar pattern except that the concentration of Qcr7p is significantly higher 
than that of Qcr8p. Therefore in both mutants formation of the subcomplex consisting of 
Qcr7p, Qcr8p and Cobp is impaired. Possibly Cbp3p is important for the incorporation of 
Qcr7p, and Cbp4p for the assembly of Qcr8p into the Cobp subcomplex. The membrane-
embedded Cobp subcomplex can be regarded as the key structure of complex III assembly. 
The crystal structure of the yeast bc1 complex (Lange and Hunte, 2002) revealed that Qcr7p is 
localised between Cyt1p and Cor1p, which are both components of the other two known 
subcomplexes of complex III. Qcr7p plays not only an important role in the stability of the 
Cobp subcomplex (Lee et al., 2001), but is also important for the assembly of the other 
subcomplexes. The higher steady state concentration of Qcr7p in the cbp4∆ mutant compared 
to the cbp3∆ mutant may explain why in the cbp4∆ mutant Cyt1p is present in a higher 
concentration in complexes corresponding in size to assembled complex III (Fig. 20). Cruciat 
et al. (2000) reported that the presence of complex III is required for the formation of 
supracomplexes. As formation of a supracomplex was also observed in a qcr6∆ mutant, 
which exhibits a 50 % reduction in complex III activity (Schmitt and Trumpower, 1990), the 
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presence of a wild type complex III seems not to be an essential prerequisite for 
supracomplex formation. In the case of the cbp4∆ mutant, an enzymatically inactive complex 
of the size of the wild type complex III is formed, suggesting that either the subunit 
composition or the three-dimensional structure is altered. Obviously this complex can be 
assembled into a supracomplex. The observation that the cbp3∆ mutant seems not to be able 
to form a supracomplex may reflect differences in the concentration or in the composition of a 
comparable inactive complex. 
The finding that respiratory growth of a cbp4∆ strain overexpressing Cbp3p from a multicopy 
plasmid under the control of a strong promoter (p426GPD) is slightly improved may be 
explained by a stabilizing effect of Cbp3p on Qcr7p, which - as discussed above - seems to be 
a key component of Cobp subcomplex formation. Perhaps the availability of a higher 
concentration of Qcr7p allows the formation of the Cobp subcomplex even in the absence of 
Cbp4p. 
 
4.3. Cbp3p and Cbp4p are presumably not involved in mitochondrial lipid metabolism 
 
The effect of cbp3∆ and cbp4∆ mutations on complex III formation may also be explained by 
participation of Cbp3p and Cbp4p in mitochondrial lipid metabolism. A correct lipid 
environment is important for the stability and function of respiratory enzymes (Dowhan et al., 
1997). Formation of supracomplexes between complexes III and IV has been shown to be 
dependent on cardiolipin, a characteristic lipid of the inner mitochondrial membrane (Zhang 
et al., 2002). Disturbances in the lipid composition of the mitochondrial membrane due to the 
mutations in the CBP3 and CBP4 gene could therefore result in the observed impairment of 
complex III and supracomplex assembly. Our data according to which the mitochondrial lipid 
composition of cbp3∆ and cbp4∆ strains shows no apparent differences to the wild type, 
argue against a role of the two proteins in lipid metabolism. This conclusion is further 
supported by our studies on mutants with an impaired cardiolipin synthesis (crd1∆) or 
remodeling (taz1∆). As expected the crd1∆ mutant strain is unable to form supracomplexes, 
in this respect resembling the cbp3∆ mutant. However, both the crd1∆ and the  taz1∆ mutant 
are not affected in complex III assembly (Fig. 28). This result and the results of BN-PAGE 
analysis of cbp3∆ and cbp4∆ strains strongly favor the idea that Cbp3p and Cbp4p are 
assembly factors specific for bc1 complex. 
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4.4. Role of Cbp3p and Cbp4p 
 
BN-PAGE analysis of cbp3∆ and cbp4∆ strains revealed the differences between these 
deletion strains, but the role of the two assembly factors remains unclear. Because of the lack 
of antibodies recognising subunits of complex III further insights into bc1 complex assembly 
and into the role of the two assembly factors in this process were studied in the strains, in 
which the subunits from different bc1 subcomplexes were tagged. In the first step the 
relationship of Cbp3p and Cbp4p with Cor1p was analysed. The essentiality of Cor1p for 
complex III assembly and activity is supported by the phenotype of cor1 mutants having 
difficulties in converting an apocytochrome b to mature cytochrome b (Tzagoloff et al., 1986; 
Gatti and Tzagoloff, 1990). BN-PAGE analysis showed that Cor1p-Tap is functional, 
transported to mitochondria and assembled into the bc1 complex. One assembly intermediate 
of Cor1p was detected in the wt strain where only Cor1p was Tap-tagged and two different 
intermediates were detected in the ZK3 strain expressing Cbp3p-HA that is partialy non-
functional and bc1-assembly seems to be less efficient. In contrast to Cor1p-subcomplex 
assembly, the Cyt1p was detected in few subcomplexes in all strains. Both, Cbp3p and Cbp4p 
are present in many complexes as observed also earlier, they have a similar distribution as 
Cyt1p, and their signal can be followed up to > 1MDa where it overlaps with the signal for 
Cor1p-Tap. These data also support the role of Cbp3p and Cbp4p in the supracomplex 
formation as discussed above. To study the role of both proteins in the bc1 complex assembly 
the effect of their deletion on Cor1p-Tap was followed. As expected, the bc1-complex in 
∆cbp4 strain is assembled and Cor1p-Tap could also be detected in the range of 
supracomplexes. Surprisingly, almost no degradation products of Cor1p are observed, but 
strong degradation of Cyt1p is observed and the bc1 complex seems to be non-functional. A 
different situation is seen in ∆cbp3 strain. Cor1p-Tap is detected in mitochondria on SDS-
PAGE (data not shown) but no signal is observed in BN-PAGE, suggesting that Cor1p-Tap is 
expressed, transported to mitochondria, but obviously not assembled into a complex (Fig. 22). 
Detection with anti-Cyt1p revealed signals preferentially in the low molecular weight range, 
suggesting that the c1-subcomplex is formed and also assembled with some other proteins, but 
not with Cor1p. This fact represents another significant difference between cbp3∆ and cbp4∆ 
strains, suggesting that the decrease of apocytochrome b in the respective null mutants may 
have different reasons, in case of cbp3∆ strain the failure of core-subcomplex assembly 
(Tzagoloff et al. 1986). These data hint at the possibility that Cbp3p plays a role in the 
assembly of the core-subcomplex with the c1-subcomplex that is probably pre-assembled with 
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the cyt b-subcomplex. These data agree with the assembly model in the existence of three 
subcomplexes, as proposed earlier (Geier et al. 1992), but change the order in which the sub-
complexes assemble into a functional enzyme. Here we propose that the cytb-subcomplex is 
first assembled with c1-subcomplex and the core-subcomplex is added in the last step (Fig. 
29). 
 
 
Figure 29. New model for complex III assembly. Three subcomplexes A, B, C are pre-assembled and then 
associate in this order: A + C = AC + B = ABC. Our data suggest that the assembly of core-subcomplex (B) 
takes place after cytb- and cyt1-subcomplexes are assembled thus modifying the model of Geier et al. (1992). 
 
BN-PAGE analysis suggested that Cbp3p could play a role in the assembly of Cor1p into bc1 
complex. The interactions of Cor1p were monitored by TAP purification method. As expected 
Cyt1p was purified with Cor1p-Tap in the wild type strain. No purification of Cbp4-cMyc 
was observed. Cbp3p-HA was detected in the eluate after purifying with CaB-beads, but lost 
in the further purification with IgG-beads. This result strongly suggests that Cbp3p may 
interact with Cor1p, but the stability of this interaction is weaked by the influence of HA-tag 
and/or by the conditions used during the TAP purification procedure. The role of Cbp3p in 
Cor1p assembly is supported also by the study of stability and assembly of Cor1p in the 
∆cbp3 strain. In this strain Cor1p is not assembled into a complex and undergoes a 
degradation. This is a striking evidence for Cbp3p acting in Cor1p stability and assembly, as 
Cor1p belongs to the most stable proteins in the deletion mutants of all structural components 
of the bc1 complex (Crivellone et al., 1988). The experiment, where ∆cbp3 strain was 
transformed with a plasmid expressing Cbp3p-cMyc to confirm the restoration of wild type 
phenotype is running, but was not completed at the time of writing this thesis. I hope we will 
be able to confirm the interaction of Cbp3p-cMyc with Cor1p and to demonstrate the role of 
Cbp3p in Cor1p assembly. Additionally, no interaction of Cor1p with Cyt1p is detected in the 
∆cbp3 strain. These data suggest a role of Cbp3p in the step of core-subcomplex insertion into 
a pre-assembled bc1 intermediate complex and are in agreement with the data of Wu and 
Tzagoloff (1989) that Cbp3p functions as chaperone in the late stage of bc1 complex 
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assembly. Interaction of Cbp4p with Cor1p was not observed. However, based on these 
results, the very similar phenotype of both cbp3∆ and cbp4∆ strains with decreased 
concentrations of cytochrome b, Qcr7p, Qcr8p (Shi et al., 2001; Crivellone, 1994) is 
surprising but as already suggested may have different causes. Therefore assembly of Qcr7p 
and Qcr8p was studied. BN-PAGE analysis of strains expressing Qcr7p-Tap or Qcr8p-Tap 
displays no difficulties in cytb-subcomplex assembly. Both proteins were detected in the high 
molecular weight range (Fig. 24 and 25). Detection with Rip1p and Cyt1p manifests that the 
bc1 complex is assembled, and Qcr7p and Qcr8p are present in the assembled complex as 
well. The fact, that cbp3∆ and cbp4∆ transformants expressing Qcr7p-HA or Qcr8p-HA could 
not be obtained, suggests strong degradation of Qcr7p-HA or Qcr8p-HA in the cbp3∆ and 
cbp4∆ strains. Based on the steady state concentraion of bc1 complex subunits in the cbp3∆ 
and cbp4∆ strains (Wu and Tzagoloff, 1989; Crivellone, 1994) we suggested that possibly 
Cbp3p is important for the incorporation of Qcr7p, and Cbp4p for the assembly of Qcr8p into 
the Cobp subcomplex (Kronekova and Rodel, 2005). However, we were not able to detect an 
interaction of Cbp3p with Qcr7p, but our data suggest the interaction of Cbp4p with Qcr8p, 
but not with Qcr7p. This latter result is in contradiction to Shi et al. (2001) who noted the 
interaction of Cbp4p with both, Qcr7p and Qcr8p.  
The main task of this thesis was finding the answer on this question: “What is the role of both 
Cbp3p and Cbp4p in the bc1 complex assembly?” Crivellone (1994) mentioned a third model 
for the role of the assembly factors. She proposed that Cbp3p and Cbp4p can act as 
scaffolding proteins during the assembly process by stabilizing associations between subunits 
in partially assembled multipolypeptide complexes. It is conceivable that the assembly 
proteins may take on more than one of these possible roles. Our data support this hypothesis 
and suggest multiple roles of these assembly factors in stabilizing protein inteactions between 
subunits during the assembly into the complex and additonally extend their roles also in 
supracomplex formation.  
Based on all data I propose the hypothesis that Cbp3p and Cbp4p form a “scaffold” for the 
assembly of all three putative sub-complexes, may act independently in the first steps of bc1 
complex assembly (e. g. the formation of sub-complexes) and interact together to assist the 
final assembly of sub-complexes into an enzyme.  
The role of Cbp4p is not clear, but we have shown that Cbp4p interacts with Qcr8p and Shi et 
al. (2001) mentioned the interaction of Cbp4p with both, Qcr7p and Qcr8p. This result 
suggests a role of Cbp4p in assembly of the cytb-subcomplex. Crystal structure of the bc1 
complex indicates that cytochrome b is the organizing component of the bc1 complex, 
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providing eight transmembrane helices (Hunte et al., 2000). Zara et al. (2004) showed that the 
presence of cytb-subcomplex is essential for the stability of other structural subunits (as 
Cor1p, Qcr7p and Qcr8p) and probably also for bc1 complex assembly. Therefore, deletion of 
CBP4 can destabilize apocytochrome b and further influence the degradation of structural 
subunits, Qcr7p and Qcr8p, thus making the phenotype of cbp4 null mutant similar to the 
phenotype of cbp3 null mutant. We have shown the interaction of Cbp4p with Cyt1p, a 
subunit of the second so called c1-subcomplex. Probably, once a cytb-subcomplex is 
assembled, Cbp4p may interact together with Cbp3p (that also interacts with Cyt1p) and 
catalyse the assembly of c1-subcomplex. Additionally, Cbp3p seems to have a further role in 
the stability and assembly of Cor1p. Cbp3p interacts with Cor1p as shown by TAP 
purification and the assembly of Cor1p in ∆cbp3 strain is disturbed. As Cbp3p interacts with 
Cyt1p as well, this suggests its essential role in the assembly of the core- and cyt1-
subcomplex. Presently we do not know, if core- and cyt1-subcomplexes pre-assemble and 
then are added to cytb-subcomplex or not. However, in the cbp4∆ strain core- and cyt1-
subcomplexes seem to be assembled into a bc1-complex-like structure, as detection of Cyt1p 
revealed a complex corresponding in size to the bc1-complex. Therefore, Cbp4p does not 
seem to be necessary for assembly of core- and cyt1- subcomplexes. Is then Cbp3p involved 
in Qcr7p stability and/or assembly into a cytb-subcomplex? What could be the reason for the 
similar phenotype of cbp3 and cbp4 null mutants? We did not show the interaction of Cbp3p 
with Qcr7p, but a role of Cbp3p in Qcr7p stability and assembly is not excluded. Qcr7p is 
located between Cyt1p and Cor1p as can be seen from the crystal structure of the bc1 complex 
(Hunte, 2001). If Qcr7p is not assembled Cor1p could possibly not be inserted. However, if 
Cbp3p is not present, the core-subcomplex could not be assembled and Qcr7p together with 
Qcr8p and Cobp that are extremely sensitive to proteases may become more accesible and 
degraded. Thus the phenotype of cbp3 null mutant would be very similar to cbp4 null mutant. 
Therefore we can not exclude the function of Cbp3p in Qcr7p stability and assembly. 
However, topology of Cbp3p and Cbp4p in respect to the topology of bc1-complex subunits 
also support the proposed model of Cbp3p and Cbp4p function and is summarised in Fig. 30. 
PK assay localised the N- and C-terminal end of Cbp3p to the matrix side of inner 
mitochondrial membrane and Cbp3p was shown to be associated with the membrane 
(Crivellone, 1994). This puts Cbp3p in the position where the core-subcomplex interacts with 
cyt1-subcomplex. Close to this position is also the position of Qcr7p. These results support 
the hypothesis that Cbp3p may act as scaffolding protein for stepwise assembly of all three 
bc1 sub-complexes. A striking difference between cbp3∆ and cbp4∆ strains is the detection of 
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one CIII/IV supracomplex in the cbp4∆ strain (Fig. 20). Although this supports the role of 
Cbp3p also in the supracomplex formation, the role of Cbp4p in this process is not excluded 
and on the other hand even supported, because formation of complete wild type 
supracomplexes is inhibited in the cbp4∆ strain. The topology of Cbp4p as shown by PK 
assay (Fig. 11) is different compared to Cbp3p. Cbp4p seems to be a transmembrane protein 
with the N-terminal end located at the matrix side and the C-terminus located in the 
intermembrane space. This enables it to function as chaperone for cytb-subcomplex assembly 
as cytochrome b is very hydrophobic and Qcr8p is located on the IMS side of the inner 
mitochondrial membrane. Additionally, a coiled coil region was predicted in the Cbp4p. The 
ability of the coiled coil domains to expose extended surfaces with amphiphilic properties 
enables them to act as scaffolds for proteins and protein complexes assemblies. This make 
Cbp4p a suitable candidate of a scaffolding protein for bc1 complex assembly. Our results 
suggest, that Cbp4p is not only essential for bc1 complex assembly, but also for supracomplex 
formation. A role of Cbp3p in supracomplex formation was also suggested by (Cruciat et al. 
2000). What are then the assembled bc1 complex-like structures detected with anti Cyt1p 
antibody in the cbp3∆ and cbp4∆ strains? Zara et al. (2004) showed that the presence of 
cytochrome b is essential for the stability of other structural subunits and probably also for bc1 
complex assembly. But concentration of apocytochrome b in cbp3∆ and cbp4∆ strains is 
reduced. Our data suggest that also in the absence or the presence of cytochrome b in low 
concentrations, the assembly of bc1-complex-like structure can occur as observed in 
cbp4∆ strain. Our data suggest that even partially assembled complex III, composed at least of 
cyt1- and core-subcomplex (in cbp4∆ strain) is sufficient for its assembly with complex IV. If 
these bc1-complex-like structures present in the cbp4∆ and cbp3∆ strains contain any residual 
apocytochrome b remains to be elucidated. This result also supports the idea that Cbp3p and 
Cbp4p may act independently in bc1 complex assembly and participate together in the 
supracomplex formation.  
Discussion 
 78 
 
 
Figure 30. Suggested roles of Cbp3p and Cbp4p in complex III assembly. Schematical drawing of Cbp3p 
and Cbp4p topology in the inner mitochondrial membrane in relationship to subunits of complex III. Interactions 
of both assembly factors with complex III subunits identified in this study are shown by blue arrows. 
 
What are the potential interaction sites of complex III and IV supracomplexes? Deletion 
analyses of subunits of the genes of complex III and IV revealed that Rip1p, Qcr6p, Qcr9p, 
Qcr10p, Cox8p, Cox12p, Cox13p and cytochrome c are not critical for formation of 
respiratory chain supracomplexes and that the lack of Qcr6p even enhanced the assembly. The 
most likely candidates for a direct link of complexes III and IV seem to be the central 
subunits: cytochromes b and c1 of complex III and Cox1p, Cox2p and Cox3p of complex IV 
(Pfeiffer et al., 2003). Cox3p was purified by co-IP with antibody directed to Cbp4p-cMyc 
(Fig. 15) supporting the role of Cbp4p in supracomplex formation. We were not able to purify 
Cox3p with Cbp3p, but Cyt1p was purified. Cytochrome b and Cyt1p together with Qcr7p of 
complex III are the subunits which are tightly bound to cardiolipin (Lange et al., 2001), on 
which the formation of supracomplexes between complexes III and IV has been shown to be 
dependent (Zhang et al., 2002).  
Therefore, I propose that Cbp3p and Cbp4p act as scaffolding proteins that fullfil their 
individual roles in bc1 complex assembly and then unite the power for successful maturation 
of the enzyme. The interaction of Cbp4p with Cbp3p may participate the formation of the 
supracomplexes, while Cbp4p seems to interact with Cox3p – a protein essential for 
supracomplex formation.  
In this thesis the role of Cbp3p and Cbp4p in complex III assembly and their relationship to 
subunits of complex III was analysed into detail. However, what is the relationship of Cbp3p 
and Cbp4p with other proteins essential for complex III assembly and biosynthesis, e.g. 
Bcs1p, Abc1p and cytochrome b translational activators? The answer for this question can be 
a task for future experiments. However, assembly of Cobp to the membrane is co-translational 
and association of Cbs2p - one of Cobp translational activators - with mitoribosomes was 
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shown by Krause-Buchholz et al. (2004). A possible assotiation of Cbp3p and Cbp4p with 
translational machinary is provided by BLAST-P analysis. Sequence similarities between 
Cbp4p and human RRBP1 protein are obtained. Human RRBP1 acts as ribosome receptor and 
mediates the interaction of the ribosome with endoplasmatic reticulum (Langley et al., 1998). 
Cbp3p shared high sequence similarity to basic FGF repressed zinc binding proteins (see 
results part, section 3.1.). Zinc binding proteins are mostly DNA-binding proteins and a 
retrovirus-like zinc domain is essential for translational repression of the bacteriophage T4 
gene 32 (Shamoo et al., 1991). The presence of fully processed cytochrome b mRNA and its 
translation in the cbp3 and cbp4 null mutants suggest that Cbp3p and Cbp4p are not involved 
in an early post-transcriptional event, but rather in a late stage of complex III assembly (Wu 
and Tzagoloff, 1989; Crivellone, 1994). We have demonstrated possible roles of Cbp3p and 
Cbp4p in the assembly of three subcomplexes. Bcs1p acts as an ATP-dependent chaperone, 
maintaining the precomplex in a competent state for the subsequent assembly of the Rieske 
Fe-S and Qcr10p proteins (Cruciat et al., 1999). Cbp3p and Cbp4p are present in the 
complexes of high molecular weight as shown by BN-PAGE. Crystal structure of complex III 
of the bovine heart mitochondria (Zhang et al., 1998) indicates that the N-termini of Rieske 
FeS interacts with Cor1 protein. It is therefore tempting to predict the presence of Bcs1p 
together with Cbp3p and Cbp4p in one complex forming a so-called “assemblosome”.  
Assembly of the bc1 complex is very complex process complicated by the presence of very 
hydrophobic proteins. Although recent data do not provide any evidence for Cbp3p and 
Cbp4p to be involved in translational machinery, the assotiation of translational and assembly 
machinery seems to be inevitable and opens new fields for further investigations. 
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5. SUMMARY 
 
Ubiquinol-cytochrome c reductase (complex III) is a central component of the respiratory 
chain of the inner mitochondrial membrane. It transfers electrons from reduced ubiquinone to 
ferricytochrome c. Correctly assembled and functional complex III is an essential prerequisite 
for oxidative energy metabolism. Complex III deficiency has been reported to be associated 
with several neurodegenerative diseases. Formation and assembly of complex III requires a 
multitude of specific nuclearly encoded proteins. For example, gene specific translational 
activators for cytochrome b synthesis as well as three non-subunit proteins, which are 
important for assembly and/or stability have been detected. The role of Bcs1p in assembly of 
Rieske FeS protein and Qcr10p into complex III has been clasified recently. The role of the 
two putative chaperones, Cbp3p and Cbp4p, is not known. 
Moreover, the process of complex III assembly is not fully understood. A model of the bc1 
complex assembly was proposed recently, in which the existence of three distinct 
subcomplexes is predicted. However, it is not known in which order the subunits interact to 
form the putative subcomplexes and in which sequence the subcomplexes are assembled into 
a functional enzyme. An excellent model to study the mitochondrial biogenesis is baker´s 
yeast, Saccharomyces cerevisiae (S. cerevisiae). In contrast to higher eukaryotes, S. cerevisiae 
can survive in the absence of the most prominent mitochondrial function, the oxidative 
phosphorylation. In S. cerevisiae, ubiquinol-cytochrome c reductase is composed of 10 non-
identical subunits with defined catalytic centers consisting of cytochrome b, cytochrome c1 
and the Rieske FeS protein. In cbp3∆ and cbp4∆ strains no complex III activity is detected 
and levels of 3 subunits (cytochrome b, Qcr7p and Qcr8p) are reduced. 
In spite of the similar phenotype of cbp3∆ and cbp4∆ strains, that suggests the role of both 
proteins in the same step of complex III assembly, we were able for the first time to 
demonstrate differences on the molecular level between both deletion mutants. We show by 
BN-PAGE that cbp3∆ and cbp4∆ mutants are disturbed in complex III assembly and 
accumulate intermediate-sized forms of the complex. Moreover deletion of CBP3 interferes 
with the formation of complex III/IV supracomplexes. Our studies show that Cbp3p and 
Cbp4p interact and are present in high molecular weight complexes, some of which might 
represent intermediates of complex III assembly. Overexpression of Cbp4p cannot substitute 
for the function of Cbp3p, but high level expression of Cbp3p can partially compensate for 
the lack of Cbp4p. Because lipids play an important role for complex III assembly and 
stability, we analysed the mitochondrial lipid composition of cbp3∆ and cbp4∆ mutants. Our 
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data show that mitochondria of both mutants exhibit a wild type-like lipid composition, that 
favors the idea that Cbp3p and Cbp4p are specific assembly factors for complex III rather 
than components of the mitochondrial lipid metabolism. 
By complementation studies we have shown that Cbp3 proteins of S. cerevisiae, S. pombe and 
human are (partially) functional homologues. A yeast model based on chimeric constructs of 
S. cerevisiae and human proteins was constructed, which allows to test the pathogenicity of 
human mutations. 
To define the role/s of Cbp3p and Cbp4p in the assembly pathway of complex III, interactions 
of selected subunits with both assembly factors were analysed by TAP- or co-
immunoprecipitation. Based on the results of Cbp3p and Cbp4p topologies, BN-PAGE 
analysis of null mutant strains and interaction studies a model for complex III assembly and 
the roles of Cbp3p and Cbp4p in this process are proposed. I present a hypothesis, according 
to which Cbp3p and Cbp4p form a “scaffold” for the assembly of all three putative sub-
complexes, may act independently in the first steps of bc1 complex assembly (e. g. the 
formation of sub-complexes) and interact together to assist the final assembly of sub-
complexes into a mature enzyme. 
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